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Abstract
Breast cancer is the most prevalent cancer and the second most common cause of cancer
death in women in the United States. This dissertation focuses on the study of food
processing modulation on breast cancer in two separate studies.
First, the soy processing effect on breast cancer was investigated. Soy flour diet
(MS) prevented isoflavones from stimulating MCF-7 tumor growth in athymic nude mice,
indicating that other bioactive compounds in soy can negate the estrogenic properties of
isoflavones. The underlying signal transduction pathways to explain the protective effects of
soy flour consumption were studied. Ovariectomized athymic nude mice inoculated with
MCF-7 human breast cancer cells were fed either MS or purified isoflavone mix (MI),
both with equivalent amounts of genistein. Positive controls received estradiol pellets and
negative controls received sham pellets. GeneChip Human Genome U133 Plus 2.0 Array
platform was used to evaluate gene expression, and results were analyzed using bioinformatics
approaches. Tumors in MS-fed mice exhibited higher expression of tumor growth suppressing
genes ATP2A3 and BLNK, and lower expression of oncogene MYC. Tumors in MI-fed mice
expressed higher level of oncogene MYB and lower level of MHC-I and MHC-II, allowing
tumor cells to escape immunosurveillance. MS-induced gene expression alterations were
predictive of prolonged survival among estrogen receptor positive breast cancer patients,
whilst MI-induced gene changes were predictive of shortened survival. Our findings suggest
dietary soy flour affects gene expression differently than purified isoflavones, which may
explain why soy foods prevent isoflavones-induced stimulation of MCF-7 tumor growth in
athymic nude mice. Future study will be conducted to characterize the composition of
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the bioactive components other than isoflavones in the soy flour diet, and their anticipated
protective effects on breast cancer growth.
Second, the link between the physical and chemical characteristics of moderately ther-
mally abused oil (TAO) and their relevance to the biological responses in breast cancer
metastasis was examined. Deep-frying is a popular food processing method worldwide.
The intake of fried foods accounts for approximately 15% of the total calorie intake in
industrialized countries, which is more than half of energy intake originating from fat.
Mounting evidence suggest that a high fat diet has a substantial impact on cancer. However,
the relationship between deep-fried food intake and breast cancer development remains
unclear. In fact, although individual latent undesirable compounds produced during deep-
frying have been shown to be carcinogenic, little is known about their impacts on breast
cancer in a whole food system. In this study, soybean oil was thermally abused and time
series data were collected. Three different foods including potato strips, chicken strips and
catfish nuggets were fried. The physical (color and viscosity) and chemical changes (peroxide
value, p-anisidine value, free fatty acid, polar component, fatty acid composition) of TAO
were characterized at different time points. Repeated exposure to high temperature, led
to significant deterioration of oil and accumulation of high concentration of undesirable
compounds. This process resulted in food-dependent changes, in the order of fish TAO
> chicken TAO > potato TAO. Most importantly, the deterioration of and undesirable
component formation in TAO positively correlated with breast cancer metastasis in the
preclinical model. This is the first study to investigate the causal link between thermally
abused oil characteristics and its direct negative biological responses in a preclinical model of
breast cancer. Future studies will be continued to characterize the undesirable components
in TAO, such as epoxy- fatty acids and cyclic fatty acids. Additional preclinical studies need
to be conducted to confirm that consumption of diets high in TAO induces more aggravated
breast cancer metastasis than diets low in TAO. More importantly, fried food can be further
incorporated into the diet, to verify the adverse impact of consuming food fried in TAO.
iii
To Yu, Yong and Quanquan.
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Chapter 1
Introduction
Breast cancer is the most common cancer among women, with estimated 231, 840 new cases
diagnosed in 2015 in the United States, of which 17% (40, 290) resulted in deaths, making
it the second most common cause of cancer death in women [1]. As the diagnosis of cancer
gets earlier and advances occurs in treatment technology, the survival rate of cancer has
dramatically increased over the past 50 years [2]. In particular, the five-year survival rate
for breast cancer patients was approximately 75% in the period of 1975 to 1977. The
survival rate increased to 84% from 1985 to 1987. It raised to 91% from 2004 to 2010 [1].
Breast cancer patients are currently living longer. This means that they will be exposed
to all the environmental factors longer, for example, e.g., diet, environmental chemicals,
tobacco smoking and obesity. Aging is an important factor contributing to higher risk of
getting breast cancer for a woman in her lifetime. The incidence rate for breast cancer
skyrocketed from lower than 10% to more than 20% after menopause [3]. Breast cancer
is most frequently diagnosed between the ages of 55 to 64. Thus, we are particularly
interested in investigating the diet influence on post-menopausal breast cancer patients using
preclinical models. Consumption of processed food increased since the industrialization in
the 20th century [4]. Food processing helps preservation of fresh produce products, and
may inactivate pathogens in the food, especially when cooking at high temperature [5]. At
the same time, certain food processing methods might produce undesirable compounds or
eliminate bioactive components. The role of food processing in dietary health has not been
subject to intensive studies [6]. The aim of this dissertation was to study food processing
modulation effects on breast cancer in two separate studies. The related literature will be
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reviewed in Chapter 2.
The first study in this dissertation focused on examining the effect of soy processing on
breast cancer, presented in Chapter 3. High soy food intake among Asian women has been
linked to low breast cancer incidence. This idea originated from the observation that Asian
women who consume soy as part of their diet have a three to five-fold lower breast cancer
risk than Caucasian women who do not consume soy food on a regular basis [7]. Currently,
soybeans and their derivatives are widely available in the Western diet. However, mostly are
consumed as supplements, or isolated soy protein, which has been extensively used in the food
industry. They are highly processed. On the contrary, soy foods consumed in Asia, such as
tofu, soy milk, are typically minimally processed. From our previous study we observed that
different food processing levels of soy products containing equivalent amounts of genistein,
modulated growth of MCF-7 cells separately in an ovariectomized athymic mice model [8].
After evaluation of the implanted tumor areas, we found that the growth of MCF-7 tumors
in mice fed on purified isoflavone mix diet was more aggressive compared with mice in soy
flour diet group. Dietary soy flour was minimally processed from raw soybean by defatting
and heating. It contained isoflavones, proteins, carbohydrates, vitamins and minerals, and
many other bioactive compounds [9]. Dietary purified isoflavone mix was highly processed by
extraction and crystallization techniques. It contained only mixed purified isoflavones. For
this reason, this chapter will elucidate whether dietary exposure to varying soy processing
levels influenced MCF-7 tumor whole-genome expression patterns differently. The goal was
to explain the underlying molecular mechanisms through high-throughput data analysis
approaches.
The second study in this dissertation was designed to investigate the link between the
physical and chemical characteristics of moderately thermally abused oil (TAO) and their
relevance to the biological responses in breast cancer metastasis in vivo, articulated in
Chapter 4. Deep-frying is a popular, fast and convenient food processing method world-
wide, for production of food with appealing sensory properties of color, flavor, texture, and
2
palatability.
Deep-frying has been commonly adopted in food industry, restaurants and households.
Fried foods account for approximately 15% of total calorie intake in industrialized countries,
which is more than half of energy intake originating from fat [10]. Deep-fried food absorbs
considerable amounts of oil during frying and cooling, which could be up to 40% [11].
Therefore, consumers take in an incredible amount of TAO along with fried food. TAO
might contain considerable amounts of undesirable compounds, such as hydroperoxides and
oxidized fatty acids. TAO characteristics could also reflect the nutritional profiles and
quality of fried food. The longer the cooking time, the more undesirable compounds will be
produced in TAO. The undesirable compounds developed in TAO might negatively impact
human health. With a parallel study conducted in our laboratory investigating the effect of
consuming TAO on breast cancer metastasis in vivo, the goal of this study was to characterize
the physical and chemical properties of TAO, frying three most commonly consumed fried
foods including potato strips, chicken strips and fish nuggets. Changes of TAO characteristics
over time and the impact of frying different fried foods used were evaluated. The implicated
biological relevance in breast cancer metastasis were discussed as well. The aim of this
study was to confirm that stimulation of breast cancer metastasis in vivo by TAO could be
linked to its characteristics. It provided pivotal scientific evidence for the food industry that
repeated thermal abuse of oil would cause direct adverse health impacts.
In Chapter 5, overall conclusions and the expectations of future research are presented.
This dissertation demonstrates food processing modulation on breast cancer from two
different perspectives. It has important implications for post-menopausal patients with
estrogen receptor positive breast cancer, to obtain isoflavones from the soy whole foods
rather than supplements. Also, this dissertation provides pivotal evidence for the food
industry, restaurants and regulatory agencies on the link between thermally abused oil and
its adverse health outcomes.
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Chapter 2
Literature Review
2.1 Food Processing and Human Health
Food processing is the branch of manufacturing that starts from raw animal, vegetable, or
marine materials and transforms them into intermediate food stuff or edible products through
the application of labor, machinery, energy, and scientific knowledge [12]. Consumption of
processed food has increased since the industrialization of the twentieth century [4]. Food
processing helps preserve fresh produce and may inactivate pathogens in the food, especially
when cooking at high temperature [5]. At the same time, certain food processing methods
might produce undesirable compounds or eliminate bioactive components [6]. The role of
food processing in dietary health has not been subjected to intensive studies.
2.2 Breast Cancer
2.2.1 Breast cancer statistics
The risk for women to develop breast cancer is estimated at one in eight in a lifetime [13].
Breast cancer is the most common cancer among women, with estimated 231, 840 new cases
diagnosed in 2015 in the United States, of which 17% (40, 290) resulted in deaths, making
it the second deadly cancer in women [1]. The average American woman’s risk of being
diagnosed with breast cancer changes with ages. Postmenopausal women have an increased
risk of breast cancer due to aging and other factors [13]. About two of three invasive breast
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cancers are found in women age 55 or older. The number of breast cancer cases is estimated
to increase from 441, 000 in 2011 to 283, 000 in 2030, especially for ER-positive in situ tumor
among women age 70 to 84 years. [14].
The number of long-term survivors of cancer is projected to increase over the next decade.
From 2012 to 2022, the number of survivors who are five years or more from diagnosis will
increase from 8.7 million to 11.9 million [2]. The five-year survival rate for breast cancer
patients was approximately 75% in year from 1975 to 1977. The survival rate increased to
84% from 1985 to 1987. It raised to 91% from 2004 to 2010 [1].
2.2.2 Causes of breast cancer
Human cancers originate from a multitude of genetic and epigenetic changes [15]. Similarly,
the causes of breast cancer are categorized as inherited gene mutations and acquired gene
mutations. BRCA1 and BRCA2 mutations account for about 20 to 25% of hereditary breast
cancer [16] and about 5 to 10% of all breast cancer [17]. Environmental exposures contribute
to the acquired gene mutations, such as diet [18], chemicals in the environment [19], cigarette
smoking [20] and being obese [21]. Considerable progress has been made investigating the
association between diet and breast cancer, which is separated into studies focusing on
dietary patterns, specific foods and biologically active food components [18]. For instance,
there is accumulating evidence that reduced fat consumption in diet may decrease the risk
of breast cancer recurrence [22]. On the other hand, high intake of deep-fried, well-done red
meat in diet may be associated with an increased risk of breast cancer [23]. A number of
epidemiological studies and animal experiments indicate that phytoestrogens could play a
role in the prevention or stimulation of breast cancer [24].
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2.2.3 Types of breast cancer
Breast cancer is a highly heterogeneous disease. Different types of breast cancer exhibit
variable histopathological and biological features, different clinical outcomes and different
responses to interventions [25]. Current established classification of breast cancer is based
on histopathological features. As indicated by World Health Organization (WHO) in 2012
[26], two major histopathological classes are invasive carcinoma of no special type (NST)
and invasive lobular carcinoma (ILC). Approximately 70 to 80% of all breast cancers
belong to either one of those two classes. More recent classification schemes are based on
the immunohistochemical characterization of breast cancer for the assessment of hormone
receptor status [25]. Approximately 80% of all breast cancers are estrogen receptor positive
(ER+), in which the cancer cells grow in response to the hormone estrogen. Approximately
65% of these are progesterone receptor positive (PR+). Cancer cells grow in response
to hormone progesterone. HER2 protein is overexpressed in approximately 20% of all
breast cancers. They are classified as HER2 positive. Between 10 and 20% of all breast
cancers are triple negative. They do not have estrogen and progesterone receptors and do
not overexpress the HER2 protein [27]. Over the last decade, a new form of molecular
classification has emerged to classify breast cancers. Breast cancers are identified into
classes of luminalA, luminalB, HER2-enriched, basal-like and normal-like subtypes by using
a hierarchical clustering analysis of gene expression profiles [28] [29] [30].
2.2.4 Tackling breast cancer with Bioinformatics
A systems biology approach to study breast cancer was initiated over a decade ago [31]. It
assembles models of biological systems from multiple systematic measurements and gives
a holistic view of the underlying biological phenomena. Under the framework of systems
biology, high-throughput genomic approaches, such as microarrays and next-generation
sequencing, are powerful means to provide insight as to how dietary factors affect the
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development of breast cancer [32].
Methods for microarray data analysis have also evolved dramatically over the past
decade [33], ranging from fold-change (FC) approaches to testing for differentially expressed
genes (DEGs), to modeling for gene networks and pathways, to many other computational
techniques. Genes that are regulated in the same fashion, that is to say, genes co-expressing
across experiments may be playing related biological or physiological roles in the biosystem
[34]. Gene clustering techniques allow similarly expressed genes to fall into the same cluster,
whereas dissimilar expressed genes fall into different clusters [35]. This serves our goal of
discovery sets of DEGs with the co-expressed patterns and distinguishing the one without co-
expressed pattern, determined by soy matrix effects on breast cancer tumor growth. Further,
those DEGs list could be viewed in the widely applied Kyoto Encyclopedia of Gene and
Genomes (KEGG) pathway platform in terms of molecular networks (KEGG pathway maps
and BRITE functional hierarchies) [36] [37]. Alternatively, the DEGs list could be analyzed
through well-accessed bioinformatics resources, such as Gene Ontology (GO) analysis [38],
to explore soy matrix effects on breast cancer tumor growth in terms of cellular component,
biological process and molecular function. This rests on the idea that statistically unordinary
events being over-represented indicates possible linkage between the treatment and biological
meaning; GO analysis is able to identify enriched annotation terms based on the DEGs list.
GO analyses could be further visualized and interpreted by enrichment map software [39], in
which automated networks functionally relate GO terms into network clusters, highlighting
the major enriched themes of GO analysis.
2.3 Soy Processing and Breast Cancer
2.3.1 Soy intake and breast cancer
High soy food intake among Asian women has been linked to low breast cancer incidence.
Asian women who consume soy as part of their diet have a 3 to 5 fold lower breast cancer
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risk than Caucasian women who do not consume soy foods regularly [40] [7] [41]. Research
on the protective effects of soy food are not conclusive. They might be confounded by other
dietary patterns and life styles that demonstrate beneficial prevention effects on suppression
of carcinogenesis. For example, Asian diets greater vegetables, fruits, green tea and smaller
portions of fat; these were shown to be associated with lower risk of breast cancer incidence
[42] [43] [44] [45] and higher survival rate among breast cancer patients [46]. Timing of
dietary estrogenic exposure may play an important role in determining breast cancer risk.
The mammary gland is extensively programmed during fetal life and then is reprogrammed
at puberty and pregnancy [47]. A hypothetical model was proposed that exposure to
dietary estrogens at pregnancy and prepubertal stages led to opposing epigenetic changes in
mammary stem cells, or uncommitted luminal or myoepithelial cells, which then modulate
the susceptibility to breast cancer risk [48]. Exposure to soy food early in life may be a key
window of opportunity for the prevention of breast cancer [49].
2.3.2 Phytoestrogens and breast cancer
Soy foods are the most common sources of phytoestrogens. Phytoestrogens are a collection
of bioactive compounds in food that share structural similarity with the hormone estrogen.
17β-estradiol is the primary form of estrogen produced in the human body. Soy isoflavone
aglycone can bind to estrogen receptors α and β; therefore phytoestrogens may mimic, block
the function of estrogen, or interrupt the normal hormonal regulatory function in the human
body [50]. Estrogenic activity of phytoestrogens influence a myriad array of functions in
human bodies, such as binding cholesterol in cardiovascular system [51], and increasing
bone density in skeletal structure [52]. The relationship between phytoestrogens and breast
cancer is a complex story. Phytoestrogens behave differently in the life-cycle depending
on factors such as timing of exposure, digestion, absorption and individual metabolism,
hormonal status, previous and current health condition, consumption of prescribed and non-
prescribed therapies, amount and profiles of phytoestrogens in foods or supplements, other
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foods and previous processing, and individual genetics [24]. Research in our laboratory [24]
suggests isoflavone dietary supplements are not recommended for breast cancer patients.
However, consuming soy from a whole food along with other legumes is likely safe.
2.3.3 Consumption of soy whole foods versus soy supplements
and breast cancer
Research from our laboratory [53] [54] indicated that genistein supplements stimulated
breast cancer growth both in vitro and in vivo in a dose-dependent manner. Dietary
genistein at and above 250 µg/g produced sufficient circulating blood levels of total genistein
[54], stimulated mammary gland growth and enhanced the growth of MCF-7 cell tumors
in ovariectomized athymic mice [53]. These studies had relevance to human exposure
by postmenopausal women with ER+ breast cancer. Soy supplements adversely affected
gene expression in breast cancer patients. In a recent randomized placebo-controlled
study of breast cancer patients who either received soy protein supplement or placebo for
7 to 40 days, soy supplements led to increased expression of several genes that induce
cell proliferation, although Ki67 expression was not increased [55]. Concerns have been
raised that soy supplements may possess adverse effects for breast cancer patients. Soy
processing levels modulate breast cancer tumor growth in vivo [8] [56]. Metabolism of soy
flour diet (MS) versus a purified isoflavone mix diet (MI) in vivo was compared in our
laboratory. Soy flour originated from defatted and toasted raw soybeans. It was minimally
processed, containing isoflavones, soy proteins, phytic acid, soluble/insoluble carbohydrates,
vitamins and minerals, and other components. Purified isoflavone mix was highly processed,
containing purely extracted isoflavones from soy. Both diets contained equivalent amounts of
genistein (750 ppm aglycone, a dose which was observed to stimulate the growth of MCF-7
tumors in vivo [53]). Purified isoflavone mix diet induced a higher plasma peak of genistein
than soy flour diet, which was more estrogenic through metabolism [56]. Average tumor area
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in mice fed diet containing purified isoflavone mix (MI) was significantly larger (91 mm2) over
an 11-week observation period than in mice fed soy flour diet containing isoflavones (MS)
(40 mm2). The average tumor area regressed in the negative control (NC) group from 40
mm2 to 16 mm2. In contrast, the average tumor area of the positive control (PC) increased
from 40 mm2 to 112 mm2 [8]. The molecular mechanisms driving the differences in purified
isolavone mix diet and soy flour diet groups remain unknown.
2.4 Thermally Abused Oil and Breast Cancer
2.4.1 High-fat diet and breast cancer
The association between dietary fat intake and breast cancer has been studied for a long
time; it remains one of the most controversial topics [57]. Most recent animal studies [58]
[59] [60] [61] [62] on high fat dietary intake indicate that it is linked to enhanced mammary
tumorigenesis, breast cancer development or metastasis. Mixed results were also reported.
Exposure to high levels of lard-based high-fat diets during early life leads to a decrease
in later susceptibility to breast cancer in animal models using Sprague-Dawley rats [63].
Hence, timing of exposure to the high-fat diet plays an important role in modulating the
development of breast cancer [63]. Due to the heterogeneity of breast cancer in the general
population, epidemiological studies provide limited evidence supporting the detrimental role
of high dietary fat intake on breast cancer prognosis and mortality rate. Results of one
randomized, prospective clinical trial [64] suggested benefits of dietary fat reduction in breast
cancer relapse-free patient survival without excluding several confounding factors such as
higher frequency of mastectomy and greater weight loss in the reduced-fat treatment group.
Recognition of the roles played by different types of fat on breast cancer survival rate and
mortality rate has occurred in the epidemiological field [65].
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2.4.2 Consumption of oil and breast cancer
It is generally agreed that high intake of dietary saturated fat [66] and trans fat are both
associated with increased breast cancer mortality and incidence rate. Intake of high-fat
dairy, as opposed to low-fat dairy relates to a higher risk of mortality after breast cancer
diagnosis [67]. In reverse, high dietary intake of vegetable fat [68], monounsaturated and
polyunsaturated fats [69], especially long-chain n-3 polyunsaturated fatty acids (PUFAs)
[70], appears to be beneficial for breast cancer patients in the long term. Oils which may
be preventive towards breast cancer. Aggregated data [71] have demonstrated that
oils possess beneficial effects on prevention of breast cancer occurrence and development. As
the major energy source of the Mediterranean diet, the effects of olive oil/extra virgin olive
oil, which are rich in monounsaturated fatty acids (MUFAs, primarily oleic acid), on breast
cancer progression and metastasis have been intensively studied using preclinical models [72]
[73]. In addition, the bioactive compounds in these oils such as oleuropein [74], squalene,
phenolic antioxidants, flavonoids and lignans were greatly studied. A large body of data
[73] indicates that olive oil/extra virgin olive oil have protective effects on breast cancer
development in animal models. It is consistent with results from epidemiological studies,
which illustrate the link between diets containing a large amount of olive oil/extra virgin
olive oil and lower incidence/mortality rates from breast cancer. Fish oil contains a large
amount of n-3 PUFAs, which in general is reported to be protective against breast cancer
[70]. A preclinical study [75] revealed that fish oil prevented breast cancer cell metastasis
to bone. Another supporting study [76] suggested that fish oil supplementation in maternal
diets high in n-6 fat during pregnancy and lactation in rats decreased breast cancer risk
in the female offspring. A whole new class of molecules named fatty acid hydroxyl fatty
acids (FAHFAs) was discovered recently [77]. They exist in small amounts within a wide
range of vegetables, fruits and meat, and can be produced and broken down in the human
body as well. They were shown to be a potential therapeutic agent to combat diabetes
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in mice and human. FAHFAs exert anti-inflammatory effects, which has been known to
be a critical component combating tumor progression [78]. Therefore, FAHFAs might fight
against cancer development as well. It also remains unclear how they are biologically and
chemically altered during food processing.
Oils which may exacerbate breast cancer. Although there is a wealth of knowledge
identifying lipids possessing preventative effects on breast cancer, much less is known about
the effects of lipids that may negatively affect health, such as thermally abused oil (TAO)
that could possibly exacerbate breast cancer progression and metastasis in animal models.
2.4.3 Deep-frying and thermally abused oil
Deep-frying is a popular cooking technique applied worldwide. Desirable flavor, golden
color and crispy texture are characteristics of deep-fried foods, which contribute to increased
energy intake in industrialized countries [79]. Fast foods are generally prepared by deep-
frying with oils used multiple times at high temperature (approximately 180 to 200°C). In
the past several decades, consumption of fast foods has soared dramatically along with the
increasing intake of food away from home. It is estimated that an adult’s daily total caloric
intake from consumption of fast food ranges from 205 to more than 350 calories [10]. The
commercial deep-frying industry has been estimated to be worth over 83 billion dollars in
the United States and at least twice that amount for the rest of the world [80]. Soybean oil
is the most widely used oil in deep-frying. Potato strips, catfish nuggets and chicken strips
are among the most popular fried foods.
Deep-frying may produce desirable or undesirable compounds in TAO. Repeated frying
cycle leads to alteration of chemical and physical properties of deep-frying oil by hydrolysis,
oxidation, polymerization, cyclisation, isomerization and other reactions [81]. Reactions
occurring in deep-frying are determined by the frying method such as replenishment of fresh
oil, frying conditions (e.g., temperature and time), frying oil, food materials, fryer, and
oxygen concentration [82].
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Two masses transfer in opposite directions during deep-frying. Water and other materials
escape from the fried food into the oil, and at the same time, food takes up incredible amounts
of frying oil. A considerable amount of TAO is thus consumed along with fried food. It is
estimated that the oil content in French fries is approximately 13 g per 100 g wet basis [83].
Common battered and breaded fried foods have increased oil contents compared to their raw
counterparts. For example, fat contents in breaded catfish are about 13.33 g per 100 g wet
basis; they are approximately 7.59 g per 100 g wet basis in the raw catfish. Similarly, the
fat content of breaded chicken (dark meat) was approximately 18.04 g per 100 g wet basis
versus only 4.31 g per 100 g wet basis in raw chicken [83]. Oil uptake rates are determined
by size, shape, and surface of the product, composition of the products and their densities,
and frying [83].
In recent years, concerns have arisen towards the link between consumption of deep-
fried food and the occurrence of malignant diseases, such as cancer, among the general
population. Epidemiological studies [23] showed that the positive association between breast
cancer risk and red meat intake was primarily restricted to those who used the deep-frying
cooking method, particularly among those who deep-fried foods to well done. Regular
intake of deep-fried foods was also reported to be associated with increased risk of prostate
cancer [84]. Epidemiological studies concluded thus far have not been able to rule out the
underlying confounding factors associated with the intake of fried food in the diet such as the
Western lifestyle. The effects of deep-fried food consumption on breast cancer have not been
extensively studied in animal models. The underlying mechanisms remain unknown. One
possible hypothesis is that the tumorigenic effects of deep-frying foods could be attributed
to the undesirable compounds generated in this specific food processing procedure. The
longer the oil is used, the less desirable the product will be. Large quantities of frying oil
are absorbed into the fried food during deep frying and therefore are being ingested during
fried-food consumption.
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2.4.4 Undesirable compounds which may occur in TAO
Deep-frying is a food processing method using oils multiple times at high temperature (above
180 °C). Undesirable compounds are produced in this process through numerous chemical
reactions such as hydrolysis, oxidation, polymerization, cyclisation and isomerization. For
instance, hydroperoxide is the primary oxidation product in lipid oxidation; decomposition
of hydroperoxide generates many secondary oxidative products, especially aldehydes; Trans
fatty acid is made by isomerization under high temperature. Preclinical studies and
epidemiological studies provide strong evidence that the undesirable compounds developed
in TAO may possess a negative impact on human health, especially on carcinogenesis. Seven
categories of undesirable compounds which may occur in TAO and their reported effects on
breast cancer will be reviewed below.
Trans fatty acid (Trans isomers). Trans fatty acids are likely produced through
isomerization under high temperature in deep-frying oil [85]. The total amount of trans
fatty acids in French fries accounts for approximately 20 mg/g after 40 cycles of frying [86].
The available evidence suggested potential associations between trans fatty acid intake and
increased breast cancer risk both in rodent models and in humans [70] [87]. Deep-fried food
is not a major source of trans fat intake in the human diet.
Acrylamide. Acrolein formed from oil reacts with asparagine and produces acrylamide
[88]. French fries contain approximately 413 ppb acrylamide and its intake range is estimated
to be from 5.00 to 26.3 µg/day [89], which tops the 2006 FDA/CFSCAN exposure assessment
for acrylamide list. Acrylamide was concluded as a human health concern by the Joint
Food and Agriculture Organization/World Health Organization Expert Committee on Food
Additives (JECFA) in 2010. Acrylamide is activated to be a carcinogen through metabolism
to glycidamide [90]. Glycidamide is the ultimate genotoxic acrylamide metabolite, which
significantly induces micronuclei formation and DNA adducts in vitro [91] and in vivo
[92]. Epidemiological studies [93] [94] indicated strong connections between exposure to
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acrylamide and breast cancer risk increase, especially endocrine related type of breast cancer
(such as estrogen receptor positive breast cancer). Reminiscent of these studies, there are
conflicting reports finding no association between human cancer risk and dietary exposure
to acrylamide in the specific population being investigated [95] [96].
Heterocyclic compounds/heterocyclic aromatic amines (HAAs). Polar amines
with an imidazo-quinoline or an imidazo-quinoxaline structure are formed when amino
acids react with carbohydrate and creatinine. Non-polar amines are produced when amino
acids react with carbohydrates [97]. Several HAAs such as 2-amino-3-methylimidazo
[4,5-f] quinolone (IQ), 2-amino-3,4-dimethylimidazo[4,5-f]quinolone (MeIQ), 2-amino-3,8-
dimethylimidazo [4,5-f] quinoxaline (8-MeIQx), and 2-amino-1-methyl-6-phenylimidazo[4,5-
b]pyridine (PhIP) were shown to be mammary gland carcinogens in rat models [98], they
cause mutations participating DNA-binding reactions. Aggregated studies focused on
investigating the carcinogenic properties of PhIP. In vitro studies [99] [100] revealed that
PhIP increased cell proliferation in MCF-7 human breast cancer cell lines, activated estrogen
alpha receptor and possibly influenced the metastatic potential of breast cancer cell lines
MCF-7 and T47D. Less is known, however, about the effects of dietary HAAs as a part of
the food system on breast cancer in animal models. The results from epidemiological studies
are inconsistent. A Swedish cohort study [101] confirmed the non-association between intake
of HAAs and breast cancer incidence, although it showed dietary patterns very high in ω-
6-PUFA may promote breast cancer development. Therefore, association between HAAs
developed in TAOs and their impact on breast cancer in animal model requires further
examination.
Cyclic fatty acid monomers (CFAMs). Essential fatty acids linoleic acid and α-
linolenic acid are the main precursor fatty acids of CFAMs, which contain five- and six-
membered rings in different positions in the original alkyl chain with two substitutes in either
cis- or trans-conformation relative to the ring. Cyclization occurs when oils rich in these
fatty acids are heated at temperatures above 200°C [102]. Several lines of evidence suggested
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that CFAMs possess toxic effects in the liver. Liver enlargement was noted in rats receiving
0.15% cyclic fatty acid esters in their diets [103], whereas CFAM - 18:3 accumulation occurs
in the liver [104]. CFAMs increase the activity of liver enzyme systems that detoxify them
[105]. On the other hand, contrasting results indicated that CFAMs may not be a major
concern for human safety. Data suggested that CFAMs are oxidized in similar ways as both
essential fatty acids [106] and do not exhibit intrinsic toxicity in rats during gestation [107].
Moreover, CFAMs were indicated to be potential mediators activating PPARα [108] and
affect different aspects of lipid metabolism [109], which possibly lead to a reduction in the
concentrations of triacylglycerols and cholesterol in the liver and plasma in the rodent models
[110]. No literature data are available on the effect of CFAMs on breast cancer development.
Polycyclic aromatic hydrocarbons (PAHs). PAHs are made up of carbon and
hydrogen atoms grouped into rings containing five or six carbon atoms. Dietary intake of
PAHs constitutes a major non-occupational source of human exposure to PAHs among non-
smokers [111] [112] [113]. For example, daily Benzo[a]pyrene (BaP) intake from diet was
estimated to range from 500 to 600 ng per day for non-occupationally exposed nonsmoker;
whereas smoking-related BaP intake was estimated to be about 180 ng per day for heavy
smokers [114], who smoke on average 18 cigarettes per day. Therefore, diet and smoking were
estimated to be major sources of non-occupational PAH human exposure. PAHs are well-
documented for their mutagenic and carcinogenic potentials in rodent models and via cell line
studies. PAHs being produced during the deep-frying from vegetable oils were postulated
to be associated with genotoxic and carcinogenic risks [115] [116] [117] in rodents. Recent
epidemiological studies [118] also supported that dietary exposure to PAHs is associated with
increase risk of several human cancers. Further, the association between exposure to PAHs
and breast cancer has also been extensively investigated. PAHs exposures were observed
to be linked with specific breast p53 tumor suppressor gene mutations [119]. BaP was
demonstrated to induce activation of signal transduction pathways and biological processes
involved in the invasion/metastasis process in MDA-MB-231 breast cancer cells [120], and
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repression of DNA mismatch repair in human ZR75-1 cell line [121]. Bap-quinones (BPQs),
which are important metabolites of Bap, were reported to increase cell proliferation, generate
reactive oxygen species and transactivate the epidermal growth factor receptor in human
mammary epithelial cell line MCF-10A [122]. Overall, PAHs developed during deep-frying
are likely to increase breast cancer progression and metastasis risk in animal models.
Hydroperoixides. Lipid hydroperoxides have been identified as the primary products
of thermally abused oil oxidation, which could be measured by peroxide value. The peroxy
radical abstracts a hydrogen atom from another oil molecule and forms hydroperoxide and
another alkyl radical [82]. Lipid peroxides from heated oils were shown to contribute to
oxidative damage in cells and peroxidation of bio-membranes [123]. Lipid hydroperoxides
have also been reported to exacerbate the development of other cancer cells, such as
hepatocarcinoma cells [124] and colon cancer cells [125] [126]. However, effects of lipid
hydroperoxides on breast cancer development have not been subjected to widely studies.
Therefore, the study being proposed will provide crucial evidence revealing the link between
TAO oxidation and breast cancer progression and metastasis in vivo.
Aldehydes. Decomposition of hydroperoxides yields aldehydes, ketones, alcohols,
hydrocarbons, volatile organic acids, and epoxy compounds, known as secondary oxidation
products [127], in which aldehydes are considered the most abundant volatile compounds
formed at frying temperature. α, β-unsaturated aldehydes, the geno- and cyto-toxocities
of which have been well known [128]. They were reported to be contained in oils after
prolonged heating at frying temperature [129]. In short, aldehydes are considered as one of
the major undesirable compounds developed in TAO due to their toxicities opposed to the
human body.
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Chapter 3
Modulation Effects of Soy Processing
On Breast Cancer Growth
3.1 Introduction
Soybeans have been incorporated into Asian diets for thousands of years, serving as good
sources of protein. The most abundant biologically active compounds in soybeans are
isoflavones, and they have been extensively studied due to their potential effects on promoting
or inhibiting carcinogenesis [8] [24]. Breast cancer is the most common cancer among women,
with estimated 232, 670 new cases diagnosed in 2014 in the United States, of which 15%
(40, 000) resulted in deaths, making it the second most common cause for cancer deaths in
women [131]. An association between high soy food intake and low breast cancer incidence
has been reported in Asian American women who continued consuming moderate levels of
soy on a daily basis compared with Asian American women who adopted Western dietary
habits [40] [7] [41]. However, the causal link between soy intake and breast cancer remains
to be established. Asian diets contained more vegetables, fruits and green tea, and less
fat than Western diets; this has been correlated with lower breast cancer risk [42] [45]
and higher survival rates among breast cancer patients [46]. Exposure to soy foods in
early life appeared to be the key window of opportunity for breast cancer prevention [49].
However, starting isoflavone supplementation when an estrogen receptor positive (ER+)
This chapter was adapted from the manuscript published in the Journal of Molecular Nutrition & Food
Research [130]. Liu Y, Hilakivi-Clarke L, Zhang Y, Wang X, Pan Yx, Xuan J, Fleck SC, Doerge DR, Helferich
WG: Isoflavones in soy flour diet have different effects on whole-genome expression patterns
than purified isoflavone mix in human MCF-7 breast tumors in ovariectomized athymic nude
mice. Molecular nutrition & food research 2015. This article is reprinted with the permission of the publisher
and is available on http://onlinelibrary.wiley.com/doi/10.1002/mnfr.201500028/abstract.
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breast cancer is present may increase breast cancer risk [53] [54]. This is supported by the
results obtained in a recent randomized placebo-controlled study in breast cancer patients
who either received soy protein supplement or placebo for 7 to 30 days [55]. Microarray
analysis indicated that soy supplementation lead to increased expression of several genes
that induce cell proliferation, although Ki67 expression was not increased [55].
Preventive effects of soy food consumption could also be due to the complex compositional
profile of bioactive compounds in soy diets other than isoflavones, referred to here as soy
matrix effects [6]. Soy foods consumed in traditional Asian diets such as tofu, soy milk
and soy flour are minimally processed from whole soybeans; whilst Western soy products
contain highly processed isoflavones extracts and soy protein isolates. We reported earlier
that minimally processed soy flour and highly purified isoflavones with equivalent amounts
of genistein influenced the growth of MCF-7 human breast cancer tumors differently in
ovariectomized athymic nude mice [8]. Average tumor area in mice fed diet containing
purified isoflavone mix (MI) was significantly larger (91 mm2) over an 11-week observation
period than in mice fed soy flour diet containing isoflavones (MS) (40 mm2). The average
tumor area regressed in the negative control (NC) group from 40 mm2 to 16 mm2. In
contrast, the average tumor area of the positive control (PC) increased from 40 mm2 to 112
mm2. The molecular mechanisms driving the differences in MI and MS groups remained
unknown.
A systems biology approach to study breast cancer was initiated over a decade ago
[31]. It assembles models of biological systems from multiple systematic measurements
and gives a holistic view of the underlying biological phenomena. Under the framework
of systems biology, high-throughput genomic approaches, such as microarrays and next-
generation sequencing, are powerful means to provide insight as to how dietary factors affect
the development of breast cancer [32].
Our current work focused on elucidating whether dietary exposures to varying soy
processing levels, but equivalent amounts of genistein (750 ppm aglycone, a dose which
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was observed to stimulate the growth of MCF-7 tumors in vivo [53]) influenced MCF-7
tumor whole-genome expression patterns differently. Compared with the previous study [8],
we focused on four treatments, which were mixed isoflavones in soy flour (SF with MI, called
MS in our study), purified isoflavone mix alone (MI), positive control (PC) that involved
treating ovariectomized mice with estradiol (E2) and negative control (NC, no hormone or
dietary treatment) groups, and applied whole-genome microarray expression analysis to the
mRNA extracted from MCF-7 tumor in the four different treatment groups. The goal was
to explain the underlying molecular mechanisms regulating the growth of MCF-7 breast
cancer tumors in ovariectomized athymic nude mice through high-throughput data analysis
approaches.
3.2 Materials and Methods
3.2.1 Animals and dietary treatments
The experimental design of the study, animals used, treatments and MCF-7 tumor collection
were described in our previous study [8]. Briefly, ovariectomized athymic nude mice at 28
days of age were randomly assigned to four groups: soy flour (MS), purified isoflavone mix
(MI), negative control (NC) and positive control (PC). The mixed isoflavone preparation
contained predominantly glycosylated isoflavones comprised of 37.2 ± 1.3% by weight
genistein, of which 0.17 ± 0.004% was aglycone, and 15.8 ± 0.7% by weight daidzein, of
which 0.19±0.008% was the aglycone. The glycetein content and other constituents were not
quantified. MS and MI groups contained equivalent amounts of genistein, and both PC and
NC groups received no genistein. All mice were fed AIN93G diet, with corn oil substituted for
soy oil. Mice in the PC group received 2 milligram estradiol (E2) pellets and mice in the NC
group received sham pellets. AIN93G based MI and MS diets contained 750 ppm genistein
aglycone and were individually formulated and balanced to contain equal amounts of protein,
carbohydrate and fat. All mice were euthanized 12 weeks after inoculation of MCF-7 tumor
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cells and tumors were immediately frozen by submersion into liquid nitrogen. All of the
experimental procedures were approved by the Illinois Institutional Animal Care and Use
Committee (Protocol ID 13315) and were conducted in accordance with the regulations
described in the Committee Manual.
3.2.2 RNA isolation and microarray Quantification
GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix, Santa Clara, CA), an oligonu-
cleotide array for 22, 680 genes containing 11 probe pairs per gene, was used. Each probe pair
consisted of a Perfect Match (PM) and a Mismatch (MM), which were identical except for
a single nucleotide change to the complement in the middle of the MM probe sequence that
allowed for determination of nonspecific binding. Analyses were carried out at the W. M.
Keck Center for Comparative and Functional Genomics at the University of Illinois, Urbana-
Champaign. In each group, RNA was isolated from tumors in three separate mice. Target
labeling was performed using total RNA for cDNA synthesis and preparing the biotinylated
antisense cRNA using SuperScript II (Invitrogen Life Technologies, Rockville, MD) and
EnzoBioArray High Yield RNA Transcript Labeling Kit (Enzo diagnostics, Farmingdale,
NY). Quality control, hybridization, washing, and scanning were performed as described
in the GeneChip Expression Analysis Technical Manual (Affymetrix, Santa Clara, CA;
Rev. 4). The microarray dataset was deposited in the National Center for Biotechnology
Information (NCBI) Gene Expression Omnibus (GEO) database (http://www.ncbi.nlm.
nih.gov/geo/) [132] [133] [134] with the accession number GSE63205.
3.2.3 Preprocessing of the Microarray data
Quality assessment, summarization, normalization, and transformation of the microarray
data were performed using the Bioconductor package for Affymetrix arrays with the R
software [135]. Three widely used normalization methods were compared, including MAS5
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[136], RMA [137] and GCRMA [138]. GCRMA was adopted based on the density plots
(Figure 3.1), box-plots (Figure 3.2) and principle component analysis (PCA, Figure 3.3) com-
paring raw data and the preprocessed data, which allowed comparisons between microarray
experiments and the control of extraneous variation among experiments. Since microarray
data are of high dimensionality, different groups are mixed in high dimensions due to the
curse-of-dimensionality. PCA was applied to extract the top-three principal components for
the purpose of comparative visualization in a three-dimensional subspace, which indicated
the dissimilarity between PC and NC treatment groups and similarity shared by MI and MS
treatment groups using the GCRMA method. A linear model was fit to the log2-intensity
transformed intensity data for each probe ID using Limma package of bioconductor [135] in
preparation for differential expression analysis of the data. The Empirical Bayes method
[139] was subsequently used to borrow information across genes making these analyses
even more stable. Present/Marginal/Absent (P/M/A) calls are good criteria to filter out
the unexpressed probes [140]. The probes which were ”Present” on at least one array or
”Marginal” on at least two arrays were reserved for further analysis; 64.52% of the total
probes were preserved after filtration.
Soy matrix effects on the whole-genome expression in ER+ breast cancer xenografted
in ovariectomized athymic nude mice were studied in two different ways: 1) Tumor-growth-
inhibiting effect uniquely possessed by MS and NC compared with PC; 2) Tumor-growth-
promoting effect uniquely possessed by MI and PC compared with NC. Following this
approach, six comparisons were made: MS versus PC (namely MSPC), NC versus PC
(NCPC), MI versus PC (MIPC), MI versus NC (MINC), PC versus NC (PCNC) and MS
versus PC (MSPC). To identify the significantly differentially expressed probes (DEPs) in
each comparison, t-tests were conducted, and DEPs were then mapped to differentially
expressed genes (DEGs). The p-values were adjusted with Benjamini and Hochberg’s false
discovery rate (FDR) control [141] using multiple hypothesis tests to correct for multiple
comparisons.
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Figure 3.1: Density Plots using three normalization methods with all Microarray
Chips. MI, purified isoflavone mix diet; MS, soy flour diet; NC, negative control diet; PC,
positive control diet.
3.2.4 Differentially expressed genes (DEGs) clustering
DEGs were selected using the FDR cutoff of less than or equal to 0.01 and log 2-fold change
of greater/less than or equal to 2. Those cutoff values were chosen based on the distribution
of the volcano-plot on contrasts (Figure 3.4), which demonstrated the log-fold expression
changes on the x-axis versus log-odds (negative log of the adjusted p-values with base
10) of differential expression on the y-axis. Six different sets of gene lists were further
extracted using the Venn Diagram technique, which corresponded to the tumor growth
inhibition (up-regulation, down-regulation and both directions) and tumor growth promotion
(up-regulation, down-regulation and both directions). Lists of genes were clustered by
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Figure 3.2: M Box-Plots using three normalization methods with all Microarray Chips.
MI, purified isoflavone mix diet; MS, soy flour diet; NC, negative control diet; PC, positive control
diet.
hierarchical clustering method [34] after expression value of each probe ID being adjusted by
row-mean values. Final clusters of genes were determined through comparisons of height cut
versus dynamic tree cut method [142] with the following parameters: method = ”hybrid”,
minimum cluster size = 1 and sensitivity to cluster splitting at the level of 3.
3.2.5 Visualization of Kyoto Encyclopedia of Gene and Genomes
(KEGG) pathways
KegArray software was utilized to explore the specific KEGG pathways involved with those
DEGs that were identified. The online application KegArray software is available in KEGG
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Figure 3.3: Principle Components Analysis (PCA) of three normalization methods
with all Microarray Chips. An array is shown as a single point in the 3-D plot, with the
geometric distance between the points representing a measure of dissimilarity of expression pattern
between arrays. That is to say, the smaller the distance between two arrays, the closer of their gene
expression patterns. MI, purified isoflavone mix diet; MS, soy flour diet; NC, negative control
diet; PC, positive control diet.
[36] [37] (Kyoto Encyclopedia of Genes and Genomes) website at http://www.genome.jp/
kegg/expression/.
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Figure 3.4: Volcano-plots of gene expression profile using an FDR = 0.01 and
| log 2(FC) = 2| cutoff to discriminate the DEGs. X-axis represents the log-fold expression
changes. Y-axis corresponds to the log-odds (Negative log10 of the adjusted p-values) of differential
expression. MI, purified isoflavone mix diet; MS, soy flour diet; NC, negative control diet; PC,
positive control diet.
3.2.6 Gene Ontology (GO) analysis
GOstats package [143] of Bioconductor was used to process GO analysis with DEGs being
identified earlier. Conditional hypergeometric tests, which removed the effects of child GO
terms when testing parents GO terms, were conducted to identify the over-represented
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annotations in four venues: cellular component (CC), molecular function (MF), biological
process (BP) and KEGG pathways. A cutoff value of the hypergeometric tests was set at
FDR of less than or equal to 0.01 obtaining enriched CC, MF and BP, while FDR was
less than or equal to 0.05 investigating enriched KEGG pathways, in order to address the
problem of dramatically increased type I errors that occurred in the multiple comparison
test.
Further, hundreds of over-represented GO terms (CC, MF and BP) which were identified
by the hypergeometric tests were visualized and organized into gene networks in the aspect
of tumor-growth-inhibiting and promoting effects using enrichment map software [39], which
was implemented as a plug-in (http://baderlab.org/Software/EnrichmentMap) for the
Cytoscape network visualization software [144].
3.2.7 Rank correlation test on the DEGs expression with
survival time of breast cancer patient
Spearman’s rank correlation tests were conducted between the DEGs expression level and
the first distant metastatic event (distant metastasis free survival, DMFS) of breast cancer
patients in three clinical datasets among 448 samples [145] [146]. Those clinical datasets
(Table 3.1) were obtained from patients with ER+ breast cancer and treated with Tamoxifen
monotherapy for five years. The DMFS of the patient samples ranged from 0 to 17 years
(Figure 3.5), which was suitable for robust rank correlation analyses. Longer survival time of
breast cancer patients was defined as more than five years; shorter survival time was defined
as less than five years. P -values of less than 0.05 were used as the threshold to identify the
significantly correlated DEGs.
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Table 3.1: Three clinical datas ets obtained from 448 breast cancer patient with
estrogen receptor positive breast cancer and treated with Tamoxifen.
Data Sets Loi JBI Loi2
Microarray Platform Affymetrix U133A Affymetrix U133A Affymetrix U133plus2.0
GEO database access
number
GSE6532a GSE17705b GSE6532 and GSE9195c
Reference [145] [146] [145]
a In total 181 early-stage (stage I, II) estrogen receptor positive breast cancer samples from
women treated with adjuvant tamoxifen monotherapy for five years, were collected from John
Radcliffe Hospital (OXFT) and Uppsala University Hospital (KIT). Batch effects of the raw
data were adjusted with an empirical Bayes batch effect adjustment method [147] in R. Further,
the log 2-intensity transformation was applied to the probe intensity. If one Entrez gene ID
mapped to multiple probe set ID, then the probe set ID with largest variance across samples
was selected.
b In total 103 estrogen receptor positive breast cancer samples (stage I, II and III) from women
treated with adjuvant tamoxifen monotherapy for five years, were collected by Institute Jules
Bordet (JBI). The log 2-intensity transformation was applied to the probe intensity. If one
Entrez gene ID mapped to multiple probe set ID, then the probe set ID with largest variance
across samples was selected.
c In total 164 early-sate (stage I, II) estrogen receptor positive breast cancer samples from women
treated with adjuvant tamoxifen monotherapy for five years, were collected from Guy’s hospital
dataset (GUYT2). 87 samples were recorded in GSE6532 and 77 samples were recorded in
GSE9195. Batch effects of the raw data were adjusted with an empirical Bayes batch effect
adjustment method [147] in R. Further, the log 2-intensity transformation was applied to the
probe intensity. If one Entrez gene ID mapped to multiple probe set ID, then the probe set ID
with largest variance across samples was selected.
3.3 Results
3.3.1 Differentially expressed probes (DEPs) between soy flour
and purified isoflavone mix
Two main probe lists of interest were identified through Venn Diagrams (Figure 3.6). Ninety-
three DEPs (0.27% of the total genes being investigated) modulated by MS were selected.
They were identified as the genes overlapping between NCPC and MSPC out of overall
overlapping genes among NCPC, MSPC and MIPC. Among those, 45 DEPs were up-
regulated and 48 DEPs were down-regulated. Therefore, those DEPs that were shared
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Figure 3.5: Histograms of the first distant metastatic event (distant metastasis free
survival, DMFS) in Loi, JBI and Loi2 Data sets among 448 samples from patients with
estrogen receptor positive breast cancer and treated with tamoxifen for five years. The
histograms illustrate that the DMFS of the samples ranged from 0 to 17 years, which is robust for
rank correlation analyses.
by MS and NC compared with PC correlated with the prevention of proliferation of the
MCF-7 tumors growth.
One-hundred and twenty-six DEPs (0.38% of the total genes being investigated) altered
by MI were selected. They were identified as the genes overlapping between PCNC and
MINC out of overall overlapping genes among PCNC, MSNC and MINC. Among those, 31
DEPs were up-regulated and 95 DEPs were down-regulated. Therefore, those DEPs that
were shared by MI and PC compared with NC correlated with the stimulation of the MCF-7
tumors growth.
Detailed information of the above screened probe IDs are provided as supplemen-
tal files (mnfr2389-sup-0002-Table1.xlsx and mnfr2389-sup-0003-Table2.xlsx), which could
be accessed online at (http://onlinelibrary.wiley.com/doi/10.1002/mnfr.201500028/
suppinfo). Their log fold-change expression value, FDR, probe set ID, gene title, gene
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Figure 3.6: Venn diagrams of the DEPs identified in different contrasts using the
FDR = 0.01 and | log(FC) = 2| as the cutoff. ”Both” sums the DEPs which were up-regulated
and down-regulated. ”UP” refers to the DEGs which were uniquely up-regulated. ”Down” refers
to the DEPs which were uniquely down-regulated. MI, purified isoflavone mix diet; MS, soy flour
diet; NC, negative control diet; PC, positive control diet.
symbol, ensembl, entrez ID, and relating BP, CC, MF in the GO, as well as KEGG pathway
information are explicitly demonstrated. Up-regulation of ATP2A3, CLU, RUNX1T1,
STAT1, and TNFRSF19 was shown to be associated with tumor-growth-inhibiting effect
by MS. These genes were down-regulated in the MI group. Thus, they might explain the
different effects of soy flour versus purified isoflavone mix on the growth of MCF-7 tumor in
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ovariectomized athymic nude mice.
3.3.2 DEG clusters linked to soy matrix modulation on breast
cancer growth
DEGs clusters modulated by MS. We focused on 93 DEPs mapping to 77 distinct entrez
gene identifiers for differentially expressed gene (DEGs) clustering. Eight clustering criteria
were compared visually in the cluster dendrogram (Figure 3.7). Twenty clusters of DEGs
were grouped across different patterns and visualized on the heat map as a color matrix
(Figure 3.9a), and categorized in Table 3.2 by their cluster ID and gene symbol. DEG
clusters modulated by MI. It was noted that 126 DEPs mapped to 100 distinct entrez
gene identifiers, and thus we focused on those DEGs for clustering. Eight clustering criteria
were compared visually in the cluster dendrogram (Figure 3.8). Twenty-six clusters were
categorized in Table 3.3 by their cluster ID and gene symbol and visualized on the heat map
(Figure 3.9b).
3.3.3 Visualization of KEGG pathways regulated by soy matrix
effects on breast cancer growth
Seventy-seven DEGs modulated by MS were mapped to 81 KEGG pathways. Visualization
of KEGG pathways of interest are provided in the supplemental file (mnfr2389-sup-0004-
Figures.docx), which could be accessed online at (http://onlinelibrary.wiley.com/doi/
10.1002/mnfr.201500028/suppinfo). Pathways in cancer contained the highest amount
of DEGs being investigated, followed by cytokine-cytokine receptor interaction, osteoclast
differentiation, proteoglycans in cancer, and JAK-STAT signaling pathway. Suppression of
oncogene MYC was present in 44 pathways investigated, potentially leading to reduced cell
proliferation and increased differentiation. Up-regulation of STAT1 was linked to 16 related
pathways. STAT1 had both tumor suppressing and promoting properties. Down-regulation
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Figure 3.7: Eight clustering criteria were applied to a cluster dendrogram on DEGs
modulated by soy flour diet (MS), which reduced MCF-7 cell growth in athymic nude
mice. ”h=2.5 clusters” represents DEGs clustered by cutting at height = 2 through hierarchical
clustering method. All the other clusters were determined by adaptive branch pruning of the
hierarchical clustering dendrograms under different selective constraint conditions. 22, 15, 14, 3,
5, 10, 21 and 26 DEGs cluseters were generated by those methods demonstrated from the top to
bottom. ”hybrid deepSplit = 3” was selected as the clustering criterion in the end.
of ADCY1 was linked to 30 different pathways, such as estrogen signaling pathway, insulin
secretion pathway, calcium signaling pathway, purine metabolism and bile secretion pathway.
Up-regulation of BLNK was associated with regulation of actin cytoskeleton in the B cell
receptor signaling pathway.
One-hundred DEGs regulated by MI were mapped to 127 KEGG pathways. Visual-
ization of KEGG pathways of interest are provided in the supplemental file (mnfr2389-
sup-0005-Figures.docx), which could be accessed online at (http://onlinelibrary.wiley.
com/doi/10.1002/mnfr.201500028/suppinfo). We observed down-regulation of MHC-I
(HLA-A, HLA-B, HLA-C, HLA-F, HLA-G), TAPBP and MHC-II (CD74) in the highly
correlated KEGG pathways. Since all these genes were involved in regulating immune
responses, such as antigen processing and presentation, adhesion molecules (CAMs) and
natural killer cell mediated cytotoxicity pathways, isoflavones were likely to suppress immune
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Figure 3.8: Eight clustering criteria were applied to a cluster dendrogram on DEGs
modulated by purified isoflavone mix diet (MI), which stimulated MCF-7 cell growth
in athymic nude mice. ”h=2 clusters” represents DEGs clustered by cutting at height = 2
through hierarchical clustering method. All the other clusters were determined by adaptive branch
pruning of the hierarchical clustering dendrograms under different selective constraint conditions.
32, 26, 17, 5, 7, 13, 26 and 37 clusters of DEGs were generated by those methods demonstrated
from the top to bottom. ”hybrid deepSplit = 3” was selected as the clustering criterion in the end.
responses. Down-regulation of EPAS1, FGFR2, STAT1, and RUNX1T1 was seen in the
pathways in cancer, suggesting that although isoflavones promoted the growth of MCF-7
tumors they inhibited pathways that induce angiogenesis and block differentiation. Down-
regulation of GNAS was linked to 31 pathways, indicating changes in signal transduction,
cell communication and endocrine functions. Down-regulation of TLR2 was associated with
16 pathways that were under categories of signal transduction, transport and catabolism,
immune system, and cancer. Similarly, down-regulation of GNB4 was linked to 12 relating
pathways under the categories of signaling transduction, immune system, nervous system
and environmental adaptation.
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Figure 3.9: DEGs expression clusters reflect soy matrix effects on MCF-7 tumor
growth in ovariectomized athymic nude mice. These clusters are demonstrated by a set
of various sidebar colors on the heat map, in which green represents a low gene expression level,
black represents medium expression and red denotes a high expression level. DEGs are in rows
and experimental groups are in columns. a. DEGs expression clusters reflect MS negates MCF-7
cell growth. b. DEGs expression clusters reflect MI stimulates MCF-7 cell growth. MI, purified
isoflavone mix diet; MS, soy flour diet; NC, negative control diet; PC, positive control diet.
3.3.4 Soy matrix modulation of breast cancer growth could be
explained via enriched GO term regulation
Significantly over-represented GO terms were summarized in Figure 3.10. The tumor-
growth-inhibiting MS up-regulated 117 Biological Process (BP) terms, which was over three
times more than that were down-regulated. MS up-regulated and down-regulated number of
Cellular Component (CC) terms similarly, as well as Molecular Function (MF) terms. GO
terms were observed to be mainly down-regulated by MI which stimulated MCF-7 tumor
growth. There were in total 204 down-regulated GO terms and 20 up-regulated terms by
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Table 3.2: DEGs clusters modulated by dietary soy flour (MS) reduce MCF-7 tumor
growth in ovariectomized athymic nude mice. DEGs in the cluster from 1 to 10 are up-
regulated. DEGs in the cluster from 11 to 20 are down-regulated.
Cluster Differentially Expressed Genes (DEGs)
1 EHF, KLK13, OAS3, ATP2A3, IFITM1
2 OAS1, IFIT3
3 CLU, TSPAN1, TNFRSF19
4 ADRA2A, PIP
5 DOCK11, SYTL2, UTRN, BLNK, REPS2
6 LIFR, DUSP10, NCOA1, B2M, ZNF704, BCL6, LOC100216479
7 GBP1, STAT1, EHF
8 FAM46A, MEIS2, SLIT2, RUNX1T1, ZNF804A
9 NPNT, KITLG, SERPINI1, RGS2
10 KLK11, CDC20B
11 NRIP1, C12orf24
12 PKIB, MCOLN2, ECE2
13 TGIF2, AK2, ZNF711
14 TGIF2, NOP16, MRPL30, FLNB, FAM126A, HEY2
15 MITF, PRR16, NECAB1
16 ADCY1, C16orf13
17 TNNT1, MYC, COL21A1
18 NLN, PGAM5, ZNF711, C20orf27, NOP16, TBRG4, LOC100506649,
C10orf2, MRPS12, C13orf18
19 C1orf135, DDX10, WDR4
20 EMP2, MRTO4, BCL11B, IL17RB, NPM3, DENND1A, SLC27A5
MI alone. Detailed GO analysis results are provided in the supplemental file (mnfr2389-sup-
0006-Figures.docx), which could be accessed online at (http://onlinelibrary.wiley.com/
doi/10.1002/mnfr.201500028/suppinfo).
Hundreds of identified over-represented GO terms were further interpreted and organized
in the enrichment map. GO terms that were modulated by MS that inhibited tumor
growth, were visualized in Figure 3.11. MS up-regulated 18 enriched GO term clusters
and down-regulated 6 clusters, which were highlighted in the enrichment map. Several up-
regulated enriched GO terms included immune responses, such as response to interferon, cell
communication, negative regulation of signaling, and regulation of molecular function, along
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Table 3.3: DEGs clusters modulated by purified isoflavone mix (MI) stimulate MCF-7
tumor growth in ovariectomized athymic nude mice. DEGs in the cluster from 1 to 5 are
up-regulated. DEGs in the cluster from 6 to 26 are down-regulated.
Cluster Differentially Expressed Genes (DEGs)
1 RAB31, PCDH11X /// PCDH11Y, CDC42EP5
2 GNB4, NEIL3, NPY1R, F12, MYB, ANKRD34A, MYBL1, EGR3
3 RPS21, PRRG1, KIF14, ZNF883, LOC401397, MRTO4, CHAC2, KIAA1524
4 TAF9B, PCDHA9, KIF23
5 TMEM45A, ANXA6
6 STAT1, TACSTD2, TMPRSS2, ASAH1, APLP2, TM4SF1, FGFR2
7 CD74, TAPBP, ATP2A3
8 NDRG2, C10orf81
9 FBXL16, MICAL2, APLP2, HLA-G, HLA-C, HLA-A /// HLA-F /// HLA-
J, HLA-B
10 CLU, EPAS1, PPAP2B, TLR2, JAG1
11 STEAP1, ARL4C
12 STEAP2, GPC4, PLBD1
13 EHF, PGCP
14 SGPP2, CAPN2, LAMP3
15 ABCA1, ABCC4, IGFBP3
16 KLK14, APOD
17 LOC100288985, MBNL2
18 JAM3, SPARC, RUNX1T1
19 IGDCC3, FILIP1L, NEDD4L
20 ARHGEF40, RBMS1, STC1
21 ZNF503, CYBB, HIPK2, COL1A1, HLA-F, VIPR1, GNAS, HLA-A,
PPAP2B, MUC20, RBM17, QKI
22 EBF1, HLA-B, ZNF423, CCDC80, VIM, KLF13, PPAP2B, LOC652147,
CDH11
23 RNF5, NEDD4L, MEIS2
24 NFIX, LOXL1, COL1A2, GABBR1 /// UBD
25 CLU, TSPAN1
26 TNFRSF19
with others. All these GO terms belong to Biological Process (BP) category. Representative
down-regulated enriched GO terms were nucleoside diphosphate biosynthetic process (BP),
neuron differentiation (BP) and cholate-CoA ligase activity (molecular function, MF).
GO terms that were modulated by MI that promoted MCF-7 tumor growth, were shown
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Figure 3.10: Conditional gene ontology (GO) analysis adopted hypergeometric tests.
DEGs were filtered by the cutoff of FDR = 0.01 and | log(FC)| = 2. Further, FDR < 0.01 is
considered as significant in the conditional hypergeometric test of GO annotations. MI, purified
isoflavone mix diet; MS, soy flour diet.
in Figure 3.12. MI up-regulated 5 enriched GO term clusters and down-regulated 8 clusters,
which were highlighted in the enrichment map. Note that 35 GO terms were clustered
into one sub-network, which related to the down-regulation of immune response (BP) and
endoplasmic reticulum (cellular component, CC). Each of their labels was shown in the zoom-
in view on top of Figure 3.12. Other down-regulated enriched GO terms in the tumor-growth-
promoting enrichment map contained cytokine production (BP), positive regulation of signal
transduction (BP), negative regulation of cell-substrate adhesion (BP), platelet binding and
activation (BP), identical protein binding (MF) and negative regulation of cell differentiation
(BP). Representative up-regulated enriched GO terms were positive regulation of histone H3-
K9 methylation (BP), F12 coagulation factor XII (BP), kinesin complex (CC), microtubule
motor activity (MF), mitotic spindle elongation (BP) and endonucleolytic cleavage (BP).
Consistent results regarding enriched KEGG pathways were obtained through conditional
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Figure 3.11: Enrichment map of GO terms distribution being regulated by soy flour
diet (MS) reduced MCF-7 tumor growth in ovariectomized athymic nude mice. FDR
Q-value cutoff ≤ 0.005 and Jaccard plus overlap combined coefficient cutoff ≥ 0.7. GO terms
failed to pass the enrichment significance threshold are not shown. Nodes are colored according to
the phenotype of the hypergeometric test of the GO terms: red denotes GO terms up-regulated
by MS; blue denotes GO terms down-regulated by MS. The color intensity is proportional to the
hypergeometric test significance (minus log FDR Q-value). Node size is proportional to the number
of DEGs in corresponding GO term. Edge thickness is mapped to the overlap of DEGs between
GO terms, which was calculated by the Jaccard plus overlap combined coefficient. Sub-networks
(that is, clusters) were determined according to the corresponding functionally related GO terms,
which were manually circled and assigned a label. The acronym in brackets represents the three
main categories of GO: Cellular Component (CC), Molecular Function (MF) and Biological Process
(BP).
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Figure 3.12: Enrichment of GO terms distribution being regulated by purified
isoflavone mix diet (MI) promoted MCF-7 tumor growth in ovariectomized athymic
nude mice. The same criteria adopted in Figure 3.11 apply here.
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hypergeometric tests, along with KegArray Software visualization (refer to File S6 for
integrated result). Under the FDR cutoff of less than or equal to 0.05, cytokine-cytokine
receptor interaction, B cell receptor signaling pathway, JAK-STAT signaling pathway and
osteoclast differentiation were up-regulated by MS. Basal transcription factors were up-
regulated by MI. Further, antigen processing and presentation, cell adhesion molecules
(CAMs), endocytosis, sphingolipid metabolism, natural killer cell mediated cytotoxicity,
fat digestion and absorption, ABC transporters and bile secretion were down-regulated by
MI.
3.3.5 Correlation analysis of gene expression level with survival
time of breast cancer patient based on soy matrix
regulation
Significantly correlated DEGs, correlation coefficients and P -values of the Spearman’s rank
correlation analyses are shown in Table 3.4 and Table 3.5. MS primarily down-regulated
DEGs (such as C1orf135, MRPS12 and TBRG4 ) that had expression levels negatively
correlated with survival time of breast cancer patient. Specifically, MS up-regulated DEGs
(such as ADRA2A), which had expression levels positively correlated with survival time
of breast cancer patient. MI primarily down-regulated DEGs (such as CD74, FRFR2,
HLA-A/B/C/F/G, VIM and Z NF423) that had expression levels positively correlated with
survival time of breast cancer patient. MI also up-regulated DEGs (such as KIF23 and
KIF14 ) with expression levels negatively correlated with survival time of breast cancer
patient.
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Table 3.4: Soy flour diet (MS) primarily down-regulated DEGs that had expression
levels negatively correlated with survival time of breast cancer patients and up-
regulated DEGs, which had expression levels positively associated with survival time.
Spearman’s rank correlation analysis was conducted between the DEGs expression level and the
first distant metastasis event (DMFS) of patients. The sign of the correlation coefficient indicates
the association between the gene expression level and survival time of patients. DEGs are denoted
in green when their expression level is positively correlated with survival time of patients. They are
denoted in red when their expression level is negatively correlated with survival time of patients.
They are underlined when they show up at least twice across three data sets. They are underlined
and in bold when they show up three times. P-values of less than 0.05 were set as the threshold of
the correlation test to identify the significant correlated DEGs.
Down-regulated by MS Up-regulated by MS
Loi
Gene Correlation
Coefficient
P -value Gene Correlation
Coefficient
P -value
C 13orf18 0.2772 0.0002 RUNX1T1 0.2031 0.0061
ADCY1 0.2584 0.0004 ADRA2A 0.1972 0.0078
FLNB 0.1669 0.0248 BCL6 0.1929 0.0092
EMP2 0.1645 0.0276 SLIT2 0.1663 0.0253
W DR4 0.1593 0.0322
MITF 0.1585 0.0331
TBRG4 -0.2631 0.0003 LIFR -0.1746 0.0188
NOP16 -0.2132 0.0040
MRPS12 -0.2390 0.0012
Z NF711 -0.16898 0.0230
C1orf135 -0.1670 0.0247
C 10orf2 -0.1589 0.0327
JBI
Gene Correlation
Coefficient
P -value Gene Correlation
Coefficient
P -value
MRPS12 -0.2548 0.0094
C1orf135 -0.2047 0.0381
C 12orf24 -0.2024 0.0403
NOP16 -0.1955 0.0478
TBRG4 -0.1952 0.0481
Loi2
Continued on Next Page. . .
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Table 3.4 – Continued
Down-regulated by MS Up-regulated by MS
Gene Correlation
Coefficient
P -value Gene Correlation
Coefficient
P -value
DDX10 0.3096 5.49E-05 DOCK11 0.3170 3.54E-05
MITF 0.2443 0.0016 N COA1 0.3022 8.40E-05
AK2 0.2320 0.0028 ADRA2A 0.2928 0.0001
I L17RB 0.2308 0.0029 EHF 0.2041 0.0012
PKIB 0.1911 0.0142 I FIT3 0.2188 0.0049
PRR16 0.1866 0.0168 RGS2 0.2175 0.0052
FLNB 0.1796 0.0213 U TRN 0.2074 0.0077
F AM126A 0.1771 0.0233 DUSP10 0.1576 0.0439
C OL21A1 0.1593 0.0416
C1orf135 -0.3053 7.04E-05 ATP2A3 -0.2428 0.0017
EMP2 -0.3026 8.21E-05 B2M -0.1637 0.0362
M RTO4 -0.2900 0.0002
T GIF2 -0.2852 0.0002
M RPL30 -0.2157 0.0055
N RIP1 -0.2017 0.0096
MRPS12 -0.1994 0.0105
TBRG4 -0.1796 0.0214
PGAM5 -0.1708 0.0288
Table 3.5: Purified isoflavone mix diet (MI) primarily down-regulated DEGs that had
expression levels negatively correlated with survival time of breast cancer patients and
up-regulated DEGs, had expression levels positively correlated with survival time. The
same criteria adopted in Table3.4 apply here.
Down-regulated by MI Up-regulated by MI
Loi
Gene Correlation
Coefficient
P -value Gene Correlation
Coefficient
P -value
CD74 0.2749 0.0002 RAB31 0.3177 1.32E-05
LOXL1 0.2555 0.0005 EGR3 0.2791 0.0001
ARHGEF40 0.2484 0.0007 TAF9B 0.2083 0.0049
Continued on Next Page. . .
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Table 3.5 – Continued
Down-regulated by MI Up-regulated by MI
COL1A1 0.2146 0.0037
COL1A2 0.2073 0.0051
FGFR2 0.2067 0.0052
RUNX1T1 0.2031 0.0061
HLA-G 0.1825 0.0139
HLA-C 0.1705 0.0217
VIM 0.1696 0.0225
SPARC 0.1683 0.0236
HLA-B 0.1646 0.0268
RBMS1 0.1576 0.0341
HLA-A 0.1560 0.0360
HLA-F 0.1536 0.0390
ZNF423 0.1524 0.0405
JAG1 0.1519 0.0412
TAPBP 0.1492 0.0451
RNF5 -0.2249 0.0023 KIF14 -0.2066 0.0053
APLP2 -0.1527 0.0402 KIF23 -0.1999 0.0070
TMPRSS2 -0.1826 0.0139 NEIL3 -0.1984 0.0074
JBI
Gene Correlation
Coefficient
P -value Gene Correlation
Coefficient
P -value
HLA-G 0.3356 0.0005 EGR3 0.3326 0.0006
HLA-B 0.3195 0.0010 NPY1R 0.2208 0.0250
HLA-C 0.2352 0.0168
HLA-A 0.2286 0.0202
CD74 0.2281 0.0204
HLA-F 0.2281 0.0205
NDRG2 0.2151 0.0291
RNF5 -0.2828 0.0038 KIF23 -0.2854 0.0035
PGCP -0.2255 0.0220 KIF14 -0.2235 0.0232
KLF13 -0.1982 0.0448 MYBL1 -0.1950 0.0485
Loi2
Gene Correlation
Coefficient
P -value Gene Correlation
Coefficient
P -value
ASAH1 0.3624 1.85E-06 LOC401397 0.2486 0.0013
CAPN2 0.3310 1.50E-05 RAB31 0.2162 0.0054
VIM 0.3154 3.90E-05
Continued on Next Page. . .
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Table 3.5 – Continued
Down-regulated by MI Up-regulated by MI
TLR2 0.3072 6.29E-05
STEAP1 0.2964 0.0001
ABCC4 0.2962 0.0001
CCDC80 0.2763 0.0003
FGFR2 0.2626 0.0007
CYBB 0.2496 0.0013
EHF 0.2438 0.0017
PPAP2B 0.2412 0.0019
NEDD4L 0.2239 0.0040
APOD 0.2094 0.0071
ZNF423 0.2019 0.0095
STEAP2 0.1908 0.0144
QKI 0.1600 0.0407
FILIP1L 0.1558 0.0464
MBNL2 -0.3664 1.40E-06 KIF23 -0.3036 7.73E-05
PUNC -0.3265 1.99E-05 MRTO4 -0.2900 0.0002
JAM3 -0.2531 0.0011 PCDHA9 -0.2559 0.0009
ATP2A3 -0.2514 0.0012 ANKRD34A -0.2497 0.0013
KLF13 -0.2382 0.0021 KIF14 -0.2449 0.0016
3.4 Discussion
We have previously shown that complex bioactive components in soy diets other than
isoflavones (other bioactive compounds in soy are referred to here as soy matrix) modulated
MCF-7 tumor growth in ovariectomized athymic nude mice [8]. Although MI was known to
promote MCF-7 tumor growth, the MS diet containing an equal amount of genistein negated
it. Previously we investigated 5 ER-related mRNA expression gene targets (pS2, PR, cyclin
D1, bcl2 and aromatase) [8]. They were up-regulated by isoflavones in purified isoflavone
mix (MI), but not by isoflavones in soy flour (MS), suggesting different levels of estrogenicity
of diets containing equivalent amounts of genistein. However, other possible molecular
mechanisms were not investigated. Our current study provides further evidence of differences
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between MS (traits shared by MS and NC comparing with PC) and MI (traits shared
by MI and PC comparing with NC) by using an integrated MCF-7 tumor whole-genome
expression, in which over 22, 000 gene expression changes were investigated. Hierarchical
clustering with DEGs (Figure 3.9) demonstrated that soy matrix modulated gene expression
in MCF-7 breast cancer tumors differently than MI. The genes that we identified as DEGs
are not just reflective of cell proliferation but also are reflective of biological pathways that if
differentially expressed in normal cells and premalignant cells, increases the risk of these cells
to undergo malignant transformation. Therefore, the DEGs are not necessarily caused by
differences in cell proliferation but they are needed for the tumors to exhibit different growth
or proliferation. By using bioinformatics tools to analyze extracted features from the heat
map, our study highlights: 1) genes promoting or inhibiting tumor growth; 2) regulation
of cancer cell signaling pathways; 3) differences in estrogen-responsive gene expression; 4)
regulation of immune responses and 5) correlation of the DEGs expression level to survival
time among ER+ breast cancer patients treated with Tamoxifen.
Inappropriate cell growth and division are restrained by some genes, which may help pre-
vent the accumulation of mutations during cancer progression. Among them are genes that
induce apoptosis. Genes that promote tumor growth often induce an increase in cell division,
reduction in cell differentiation and inhibition of apoptosis. These genes have recently been
linked to epigenomic programming of tumor initiating stem cells [148]. A large body of data
[149] [150] has documented that activation of tumor-growth-promoting oncogenes and/or
inactivation of tumor-growth-inhibiting genes function together to exacerbate breast cancer
tumor progression. In contrast, inhibition of oncogenes and/or activation of genes that can
inhibit tumor growth prevent progression of breast cancer. We identified ATP2A3, BLNK,
CLU, RUNX1T1, STAT1, and TNFRSF19 as up-regulated by MS; however, it is unclear
whether these genes can explain the protective effects of MS on MCF-7 tumor growth. For
example, ATP2A3 has been reported to influence predisposition to cancer development by
changing the cell and tissue environment [151]. Although STAT1 was acting as a tumor
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suppressor gene in some studies [152], several recent findings suggested that STAT1 acted
as an oncogene and its high expression level was linked to resistance to cancer treatments
and poor survival [153].
MS down-regulated MYC expression. It is well known that MYC is an estrogen-
responsive gene [154], which participates in cell cycle regulation and MYC promotes
proliferation of MCF-7 breast cancer cells [155]. MYC is down-regulated via the PI3K-
AKT pathway [156]. We also observed that oncogene MYB was up-regulated by MI. Up-
regulation of MYB was associated with ER+ breast cancer and reported to be critical for
tumor cell growth, especially during an early period in mammary tumor development when
it appeared to be imperative for tumor initiation [157]. A previous study demonstrated that
MYB expression was induced by estrogen [155] in MCF-7 cells inoculated into ovariectomized
athymic nude mice. Here, we confirm that MI mimicked the effects of E2 in affecting gene
expression. Our findings suggest that MI stimulated MCF-7 tumor growth by increasing
expression of tumor promoting genes.
MI down-regulated notch ligand JAG1 in the notch signaling pathway, which among
many of its functions propels mammary stem cells to commit to differentiation [158][45].
Epigenetic alterations might also be affected by soy matrix through chromatin modification.
Different levels of modulation were observed on transcription by soy matrix effects (File S6);
for instance, MI up-regulated genes that regulate histone H3-H9 methylation. MS and MI
had opposing effects on other cell survival pathways [159], including cell cycle/apoptosis,
RAS, PI3K, STAT, MAPK and TGF-β pathways (Please refer to mnfr2389-sup-0004-
Figures.docx and mnfr2389-sup-0005-Figures.docx, which could be accessed online at http:
//onlinelibrary.wiley.com/doi/10.1002/mnfr.201500028/suppinfo). MI also sup-
pressed genes that regulate apoptosis, such as CAPN2. This finding is consistent with
previous studies showing that soy protein supplementation upregulated expression of the
genes relating to cellular growth and proliferation, cell cycle, cell death and survival in breast
cancer patients [55]. Collectively, we report that soy matrix did not induce similar adverse
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signaling changes, which were linked to increased cancer cell growth, to those induced by
MI.
As mentioned earlier, complex bioactive components in soy may modulate the estrogenic-
ity of diets containing equivalent amounts of genistein [8]. In a separate study [56], BALB/c
mice fed MI diet had higher peak plasma levels of the active estrogenic aglycon form of
genistein compared with mice fed MS. The results from the metabolism and deposition study
of dietary isoflavones [56] indicate that MS diet reduced the aglycon content of genistein
which may, in part, explain the lower estrogenic response in mice fed MS. The present study
was designed to evaluate genome-wide effects and the results here provide further evidence
that soy matrix significantly altered the estrogenicity of diet.
MS down-regulated the expression of estrogen-responsive genes, such as NRIP1
(RIP140) and IL17RB. RIP140 is required for normal mammary gland development,
estrogen-dependent transcription regulation, cell proliferation in breast cancer, and
functions as a co-activator for ERα-responsive genes. High RIP40 expression was linked
to poor survival of breast cancer patients [160]. IL17BR was significantly increased by
E2 in the MCF-7 cell line. Our data thus suggest that IL17BR is an estrogen-responsive
gene, which is consistent with its positive correlation with ER status in primary breast
cancer tumors [161]. BLNK is a potential tumor suppressor gene in breast cancer, since it
inhibits MCF-7 cell growth and has been identified to be strongly repressed by E2 [162].
MS up-regulated BLNK expression. MI enhanced expression of estrogen-responsive genes,
such as MYBL1 (B-MYB) and ERG3. B-MYB has been shown to promote cell survival
by activating anti-apoptotic genes in breast cancer [163]. It was also shown to be strongly
induced by E2 in the MCF-7 cell line [164] and was identified as one the overexpressed DEGs
in breast cancer patients on soy protein supplementation diet compared with the placebo
group [55]. ERG3 has been shown to be rapidly induced in estradiol-treated MCF-7 cells
[165]. The transcription factor EGR3 is the bona fide target gene of ERα and involved in
the estrogen-signaling pathway in breast cancer [165]. Our observations strongly suggest
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that MS negated the estrogenic properties of isoflavones by modulating estrogen-responsive
gene expression.
Data shown in Figure 3.11 and Figure 3.12 demonstrated how immune responses were
regulated by bioactive compounds found in soy matrix. Numerous immune response GO
terms were up-regulated by MS. In contrast, MI caused a down-regulation of several immune
response GO terms. DEGs cluster 9 (Table 3.3) that was modulated by MI contained many
immune-related genes, such as HLA-G, HLA-C and HLA-A. Avoiding immune destruction
by T and B lymphocytes, macrophages, and natural killer cells has been suggested to be
an emerging hallmark of cancer [166]. In support of the notion that immune response
is closely regulated in cancer, we observed that MS up-regulated lymphocyte mediated
immunity (BP). On the other hand, MI down-regulated the positive regulation of lymphocyte
mediated immunity (BP), positive regulation of macrophage cytokine production (BP) and
natural killer cell mediated cytotoxicity (KEGG pathway). Previous studies have reported
several T-cell mediated antitumor immune responses by isoflavones, including by genistein,
in immunocompetent mice, rats and humans [167]. Since the results in our study were
generated in athymic mice that are T-cell deficient, it is possible that T-cells are required for
purified isoflavones to elicit antitumor immune responses and inhibit tumor growth. Further,
our data indicate that soy matrix can provide antitumor immune responses in athymic nude
mice that have B-cells and natural killer cells.
Previous studies indicated that reduced dietary fat consumption and increased fiber,
vegetable, fruit and other nutrient intake associated with a plant-based, high-fiber diet
improved overall survival rate of breast cancer patients [46]. Our study here elucidates
how soy matrix effect might alter ER+ survival time of breast cancer patients. Kinesins are
a superfamily of motor proteins and they have been reported to be deregulated in different
cancers. A recent study revealed that estrogen strongly induced the expression of 19 kinesin
genes in ER+ breast cancer cells. Elevated kinesin gene expression was correlated with
poor relapse-free survival of ER+ breast cancer patients [168]. KIF23 and KIF14 were up-
48
regulated by MI in our study, and their expressions levels were negatively correlated with
survival time of breast cancer patient across all three clinical datasets being investigated.
BRCA1 functions as an important tumor suppressor gene in breast cancer [169]. ZNF423
participates in the estrogen-dependent induction of BRCA1 expression, and an estrogen-
inducible BRCA1 transcription factor, which is associated with decreased risk for breast
cancer occurrence in selective estrogen receptor (SERM) therapy [170]. In the present
study, MI down-regulated ZNF423 gene that is associated with longer survival times among
ER+ breast cancer patients. Concurrently, gene expression of the major histocompatibility
complex (MHC ) family, such as HLA-A/B/C/F/G was suppressed by MI, which might lead
to shorter survival time of breast cancer patients. MHC molecules were of vital importance
in regulating immune responses against cancer [171], and the expression level of MHC was
positively correlated with survival time of patient.
Collectively, this study is the first to elucidate the underlying molecular mechanisms
modulated by the complex nature of the components in soy in a systematic fashion. In the
future, studies will be conducted to characterize the composition of bioactive components
other than isoflavones in the soy flour diet, and their anticipated protective effects on
breast cancer growth will be investigated. Further, studies will be designed to demonstrate
that the genomic changes observed by us impact cancer cell proliferation and apoptosis.
The results obtained in this study provide strong evidence that there is a difference in
biological responses between consumption of soy flour versus purified isoflavone mix in the
ovariectomized athymic nude mouse model of breast cancer.
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Chapter 4
Characterization of Moderately
Thermally Abused Oil That May
Promote Breast Cancer Metastasis
4.1 Introduction
Women with breast cancer account for 22% of all cancer survivors, they are living longer
with breast cancer [2], therefore there is more time for their health to be influenced by diet.
The association between dietary fat intake and breast cancer has been studied for a long
time, it remains one of the most controversial topics in the nutritional field [57]. There is a
wealth of knowledge identifying lipids possessing preventative effects on breast cancer. Diet
containing a large proportion of olive oil/extra virgin olive oil may have protective effects
on breast cancer [71] [73]. However, much less is known about the effects of lipids that may
negatively affect health, such as thermally abused oil (TAO) that could possibly exacerbate
breast cancer progression and metastasis in animal models.
Deep-frying is a popular cooking technique applied worldwide. It is estimated that an
adult’s daily total caloric intake from consumption of fast food ranges from 205 to more than
350 calories [10]. Soybean oil is the most widely used oil in deep-frying. Potato strips, catfish
nuggets and chicken strips are among the most popular fried foods. In recent years, concerns
have arisen towards the link between consumption of deep-fried food and the occurrence of
malignant diseases, such as cancer, among the general population. Epidemiological studies
[23] showed that a positive association exists between breast cancer risk and red meat intake;
this was primarily restricted to those who used the deep-frying cooking method, particularly
among those who deep-fried foods to well done. Regular intake of deep-fried foods was
also reported to be associated with increased risk of prostate cancer [84]. Epidemiological
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studies conducted thus far have not been able to rule out the underlying confounding factors
associated with the intake of fried food in the diet such as the Western lifestyle. Effects of
deep-fried food consumption on breast cancer have not been extensively studied in animal
models. The underlying mechanisms remain unknown. One possible hypothesis is that the
tumorigenic effects of deep-frying foods could be attributed to the undesirable compounds
generated in this specific food processing procedure. The longer the oil is used, the less
desirable the product will be. Large quantities of frying oil are absorbed into food during
deep frying; therefore this oil is ingested during fried-food consumption. This study focused
on the characterization of the undesirable compounds in TAO, which may have a link to
breast cancer progression and metastasis in the preclinical mouse model of breast cancer.
Deep-frying is a food processing method that typically uses oils multiple times at high
temperatures (above 180°C). Undesirable compounds are produced in this process through
numerous chemical reactions such as hydrolysis, oxidation, polymerization, cyclisation and
isomerization. Reactions occurring in deep-frying are determined by the frying parameters
such as replenishment of fresh oil, frying conditions (e.g., temperature and time), frying
oil, food materials, fryer, and oxygen concentration [82]. In the current study, it was of
interest to evaluate the impact of food materials on reactions occurring during deep-frying.
Evidence derived from a vast array of laboratory studies and epidemiological investigations
have implicated that the undesirable compounds which may develop during deep-frying such
as trans acids [70] [87], acrylamide [91] [92] [93] [94], HAAs [99] [100] and CFAMs [103], might
possess negative impacts on human health, especially on carcinogenesis. However, none of
these studies investigated all the undesirable compounds as a whole and looked into how
they modulate the breast cancer metastasis in vivo as a complex food system.
Preliminary data were obtained form a parallel study conducted by another graduate
student Anthony Cam in our laboratory. The effects of TAO on breast cancer metastasis were
investigated in a mouse model of breast cancer, with post-menopausal women having triple-
negative breast cancer as the target human population. Ovariectomized female BALB/c
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mice of 4 weeks of age were randomly assigned to 8 dietary treatment groups with a two-
by-four two factorial design. Each group included 21 mice. The two factors were diet
and TAO respectively. Factor diet contained two levels: low-fat diet and high-fat diet.
TAO contained four levels: fresh soybean oil and potato/chicken/fish TAOs. Four low-
fat dietary treatment groups possessed 10% fat by weight, which were the fresh soybean
oil or end potato/chicken/fish TAOs respectively. Those four high-fat dietary treatment
groups included 24% fat by weight, in which 10% were the fresh soybean oil or end
potato/chicken/fish TAOs respectively. 7% lard and 7% milk fat were used to supplement the
rest of fat in each high-fat group. End potato/chicken/fish TAOs were separately produced
after 16 h of intermittent high temperature thermal treatment, the detailed production
method will be elaborated in 4.2.1. After 16 weeks of dietary treatment, 4T1 luciferase
expression metastatic murine breast cancer cells (1× 103) were injected into each mouse by
tibial injection. All mice were euthanized at week 20 after 4 weeks of post-injection dietary
treatments. The tumors formed by 4T1 cells were counted on the lung surface area, which
were metastasized from the bone, which was the primary injection site. The average mean
value of three technical replicates for each mouse were reported as the tumor nodule count.
It was shown that fish TAO exacerbated breast cancer metastasis in vivo compared to
the fresh oil in the four low-fat dietary treatment groups, but not in the four high fat groups
(Figure 4.1). Potato TAO resulted in a significantly higher tumor nodule count (TNC)
supplemented with high-fat diet comparing with supplemented with low-fat diet. However,
note that there were no significant differences between the TNC of potato TAO groups and
fresh oil groups supplemented either with high-fat diet or low-fat diet.
The central hypothesis was that the thermal abuse of oils during processing of deep-
fried food will lead to products with distinct physical/chemical characteristics and to the
accumulation of undesirable components with unique chemical properties, including the
ability to increase breast cancer progression and metastasis as elucidated in rodent models.
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Figure 4.1: Fish TAO exacerbated breast cancer metastasis in vivo from bone to lung
comparing with the fresh oil in the low-fat dietary treatment groups, not in the high
fat groups. Fresh oil is represented by gray bar. Potato/Chicken/Fish TAO groups are denoted by
red/green/blue bars respectively. Two-way ANOVA analysis was conducted following the original
experimental design. The overall p-value was 0.03. The interaction effect of the two factors was
observed to be significant (p=0.03). Therefore, One-way ANOVA analysis was further conducted to
compare the difference across all eight dietary treatment groups. Multiple comparison test adjusted
for fdr was further utilized. Groups with different letters assigned indicate they were significant
different from each other.
4.2 Materials and Methods
Potato strips, chicken strips and catfish nuggets were selected for deep-frying in soybean
oil (the most common commercial frying oil) in triplicate, because they are the most
popular fried foods consumed in the United States. In addition, each food chosen has a
unique chemical composition, thus the profiles of their products after deep-frying would be
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drastically different from each other. The various foods were fried intermittently for 16 h at
180±5°C in a commercial countertop deep fryer. The setting is consistent with the common
practice in fast-food restaurants and deep-frying industry.
4.2.1 TAOs production and sampling
Oils and foods
Commercial physically refined soybean oils were obtained from Whole Harvest Foods, LLC
(Warsaw, NC). French fries were made out of freshly cut Idaho potato (using a French
fry cutter). Home-style chicken breast tenderloins (small, uncooked, balanced fritters,
breaded and battered) were obtained from Tyson Foods, Inc (Springdale, AR). As shown
on its food label, chicken breast tenderloin fritters contained up to 15% of a solution of
chicken broth, soy protein concentrate, sodium phosphates, sugar, salt, flavoring. The
chicken breast tenderloins fritters were breaded with wheat flour, salt, leavening (sodium
bicarbonate, sodium aluminum phosphate, monocalcium phosphate), wheat gluten, spices,
garlic powder, onion powder, natural flavor. Their batter was comprised of water, wheat
flour, salt, leavening (sodium bicarbonate, sodium acid pyrophosphate, sodium aluminum
phosphate, monocalcium phosphate), disodium inosinate and disodium guanylate. They
were also predusted with wheat flour, wheat gluten, and salt. Raw skinless breaded catfish
nuggets (domestic farm raised) were obtained from Bluewater Seafood, Co. (Peabody,
MA). As shown on the label, the ingredients of the catfish nuggets included catfish, water,
yellow corn meal, bleached wheat flour, salt, modified food starch, leavening (sodium
bicarbonate, sodium aluminum phosphate), sodium tripolyphosphate, dehydrated onion,
paprika, partially hydrogenated soybean oil, spices, dried egg whites, wheat gluten, silicon
dioxide (anti-caking agent), sodium hexametaphosphate, sodium alginate, xanthan gum.
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Fryer and French fry cutter
Commercial countertop deep fryer (Figure 4.2(a)) was obtained from The Vollrath Company,
LLC (Sheboygan, WI) with a capacity of retaining 15 pounds oil. The French fry cutter
(Figure 4.2(b)) was obtained from Weston Products LLC (Strongsville, OH). This cuts
potatoes up to 6 inches long into 3/8 inch diameter French fries.
Frying procedure and sampling
Intermittent frying was performed at 180± 5°C using 15 lbs oil for 4 h/day over 4 d without
replenishment of oil. Frozen food products were thawed overnight at 4°C. Potato strips,
breaded chicken strips and skinless breaded catfish nuggets were fried in three separate
fryers. For each cycle, a batch of 400 g of product was fried for the following times: French
Fries 11 min, chicken strips 10 min, and fish nuggets 5 min. The total cycles performed for
the potato, chicken and fish were: 50, 45 and 65. Thus, the total weights of potato, chicken
and fish being fried were: 20 kg, 18 kg and 26 kg corresponding to active frying total time:
550 min, 450 min and 325 min.
Sampling cycle points for TAO frying potato were: 5, 10, 20, 30, 40 and 50. Sampling
cycle points for TAO frying chicken were: 5, 10, 20, 30, 40 and 45. Sampling cycle points for
TAO frying fish were: 5, 10, 20, 30, 40, 50, 60 and 65. Approximately 250 mL of oil sample
was taken at each sampling point, flushed with an inert gas and stored in the dark at
−20°C for TAO characterization. End potato/chicken/fish TAOs were sampled from their
corresponding frying cycle 50/45/65. End TAO products were utilized in a parallel preclinical
study, the preliminary data of which was presented in 4.1. Three frying trails were conducted.
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(a) Deep Fryer (b) French Fry Cutter
Figure 4.2: Frying Equipment. Commercial countertop deep fryer with a capacity of retaining
15 pounds oil was utilized. French fry cutter cut potatoes into 3/8 inch diameter French fries.
4.2.2 Characterization of physical properties of TAOs
Measurement of color
A Hunter colorimeter (HunterLab, Reston, VA, USA) was used to measure the color in
L?a?b? mode. L? is on the lightness axis (0 is black, 100 is white and 50 is middle gray). a?
is on the red-green axis (positive values are red, negative values are green and 0 is neutral).
b? is on the blue-yellow axis (positive values are yellow, negative values are blue and 0 is
neutral). The instrument was first standardized with black and white reference tiles. Each
sample was measured for three times. Color changes of oil samples were further analyzed by
the total color difference, which is defined as ∆E? (Equation 4.1).
∆E? =
√
(∆L?)2 + (∆a?)2 + (∆b?)2 (4.1)
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Measurement of viscosity
Rheological characteristics and viscosity of the frying oil were investigated by ARES-G2
Rheometer (TA Instruments, New Castle, DE, USA) under an air bearing pressure of 100 psi
(∼ 700 kpa). The samples were measured with cup (30 mm diameter) and DIN bob (27.679
mm diameter, 41.615 mm length) geometries. The flow-sweep experiment was performed
under constant temperature of 25°C with shear rate increasing from 1.0 to 100.0 at the
accelerating speed of 1 per second. Sampling points were reported every decade of shear rate
increase. In total 21 points were collected. The viscosity of each oil sample was calculated
as the average of the 21 data points after the confirmation that the oil is Newtonian fluid.
The viscosity of the Newtonian fluid is constant as the shear rate changes. Viscosity of oil
were sampled every 20 cycles.
4.2.3 Characterization of chemical properties of TAOs
Measurement of oxidation
Hydroperoxides are the primary oxidation products. Peroxide value (POV) was determined
according to AOAC Official Method 28.022-3 [172]. P-anisidine value is an indicator of the
degree of secondary oxidation reactions. It determines the amounts of aldehyde present in the
oil due to thermal decomposition of the hydroperoxides. P-anisidine value was determined
by AOCS Official Method Cd 18-90 [173].
Measurement of hydrolysis
The amount of free fatty acid (FFA) in fats and oils can be used to indicate the extent of its
deterioration due to hydrolysis of triglyceride and/or cleavage and oxidation of unsaturated
fatty acid. FFA value was determined by AOCS Official Method Ca 5a-40 [173].
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Measurement of polymerization
The total amount of polar components were determined by AOCS Official Method Cd 20-91
[173].
Fatty acid composition analysis
Fatty acids were derivatized into methyl esters prior to analysis by gas chromatography
(GC). In detail, 30 mg of each sampled oil was accurately weighed and 10 mL chloroform
added to 1 mL of the solution. 300 µg of internal standard (heptadecanoic acid) was added.
After drying under nitrogen, 2 mL methanolic HCl (4%) was added. The solution heated
(∼ 90°C) 40 min. After cooling, 3 mL hexane and 1 mL water were added and the hexane
phase was extracted and dried under nitrogen. The solution was re-suspended in 0.5 mL of
hexane and used for further analysis.
Fatty acid methyl esters (FAMEs) were analyzed on a GC (5890 series II Hewlett Packard)
using the SPTM−2560 capillary column (75m × 0.18 mm × 0.14 µm film thickness; Supelco,
Bellefonte, PA, USA). Helium was used as the carrier gas with flow rate of 1.5 mL/min.
Column temperature was programmed from 100°C (held 5 min) to 240°C at 4°C/min held
40 min. Flame ionized detector temperature was set at 250°C. 1µL FAMEs samples were
injected. Fatty acids was identified by comparing the retention time of the Supelco 37-
component FAME mix (CRM47885); Table 4.1.
Table 4.1: Components of Supelco 37 FAME mix standard, C4-C24. Fatty acids in TAO
were identified by comparing with the retention time of the 37 standard fatty acid FAMEs mix,
which components are demonstrated in this table.
Peak
Identifier
Component Common Name Numerical
Abbreviation
1 Methyl butyrate 4 : 0
Continued on Next Page. . .
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Table 4.1 – Continued
Peak
Identifier
Component Common Name Numerical
Abbreviation
2 Methyl hexanoate 6 : 0
3 Methyl octanoate 8 : 0
4 Methyl decanoate 10 : 0
5 Methyl undecanoate 11 : 0
6 Methyl laurate 12 : 0
7 Methyl tridecanoate 13 : 0
8 Methyl myristate 14 : 0
9 Myristoleic acid methyl ester 14 : 1
10 Methyl pentadecanoate 15 : 0
11 Cis-10-pentadecanoic acid methyl ester 15 : 1
12 Methyl palmitate 16 : 0
13 Methyl palmitoleate 16 : 1
14 Methyl heptadecanote 17 : 0
15 Cis-10-heptadecanoic acid methyl ester 17 : 1
16 Methyl stearate 18 : 0
17 Trans-9-elaidic acid methyl ester t18 : 1
18 Cis-9-oleic acid methyl ester 18 : 1
19 Linolelaidic acid methyl ester t18 : 2
20 Methyl linoleate 18 : 2
21 Methyl arachidate 20 : 0
22 Gamma-linolenic acid methyl ester 18 : 3n6
23 Methyl eicosanoate 20 : 1
24 Methyl linolenate 18 : 3n3
25 Methyl heneicosanoate 21 : 0
26 Cis-11,14-eicosadienoic acid methyl ester 20 : 2
27 Methyl behenate 22 : 0
28 Cis-8,11,14-eicosatrienoic acid methyl ester 20 : 3n6
29 Methyl erucate 22 : 1n9
30 Cis-11,14,17-eicotrienoic acid methyl ester 20 : 3n3
31 Cis-5,8,11,14-eicosatetraenoic acid methyl ester 20 : 4
32 Methyl tricosanoate 23 : 0
33 Cis-13,16-docosadienoic acid methyl ester 22 : 2
34 Methyl lignocerate 24 : 0
35 Methyl cis-5,8,11,14,17-eicosapentaenoate 20 : 5
36 Methyl nervonate 24 : 1
37 Cis-4,7,10,13,16,19-docosahexaenoic acid methyl
ester
22 : 6
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4.2.4 Statistical analysis
Data are presented as means ± standard error of the mean (SEM) from three replicates. All
statistical analyses were conducted using the software R [174]. Changes of each parameter
over time were analyzed with the (normal) multiple linear regression model with repeated
measures. As shown in Equation 4.2, frying time and TAO were modeled as two independent
factors in the regression model. Frying time was considered as a continuous variable, while
TAO was considered as a categorical variable with three different levels (potato TAO, chicken
TAO and fish TAO). The significance of coefficients for the Time and TAO were tested
through multiple linear regression. P -value of coefficients (β1 and β2) were obtained to
demonstrate the effect of time and TAO separately. Time change rate of each parameter
was calculated based on value of coefficients (β1 and β2). The significant differences of the
TAOs characteristic in the end frying time and the fresh soybean oil were compared by One-
way Analysis of Variance (ANOVA). Multiple comparison test adjusted for fdr was further
conducted to declare the within group significant differences if the One-way ANOVA test was
significant. Spearman’s correlation test was conducted to test the significance of correlation
between end TAO characteristics and average metastatic lung TNC in mice fed with four
low-fat diets. Four diet groups were fresh oil, potato/chicken/fish TAO, which contributed
to the 10% fat by weight in low-fat diets. The TNC of fish TAO was significantly higher
than the fresh oil group (Figure 4.1). P -value of less than 0.05 was set as the significant
threshold for the all statistical tests.
Y ∼ β0 + β1Time+ β2TAO +  (4.2)
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4.3 Results
4.3.1 Color changes of TAO over time
The color of the frying oil changed as it was subjected to repeated frying cycles (Figure 4.3).
The three-dimensional scale L?, a? and b? that was utilized to instrumentally measure color
reflects the perception of color by human eyes.
Figure 4.3: The color of the frying oil changed over time. The number denotes the
corresponding frying cycle of each sample. PO, potato TAO; CO, chicken TAO; FO, fish TAO.
Thermal abuse of the oil significantly reduced its lightness (L?) as the frying time
increased (Figure 4.4 and Table 4.2). The lightness of the frying oil decreased sharply in the
first 50 minutes of accumulative frying time. It kept decreasing at a slower rate afterwards.
The lightness decrease rate of the oil was the fastest in fish TAO, followed by chicken and
potato TAOs, which were statistically significant different from each other. The estimated
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average lightness decrease rates for potato/chicken/fish were 0.028/4.000/4.417 per minute.
Thermal abuse of the oil significantly increased its redness (a?) as the frying time
increased (Figure 4.4 and Table 4.2). The redness increase rates in fish and chicken
TAOs were significantly higher than the potato TAO. No significant difference was observed
between the increase rate of a? in the fish and chicken TAOs. The estimated average redness
increase rates for potato/chicken/fish were 0.029/4.894/4.705 per minute.
The yellowness (b?) of the oil rapidly elevated as it was thermally abused (Figure 4.4 and
Table 4.2). Starting from approximately 200 minutes, the yellowness of the fish and chicken
TAOs declined slightly. The yellowness of the potato TAO started to slightly decline at
approximately 330 minutes. The yellowness increase rate in fish TAO was significantly higher
than the rate in potato TAO. No significant differences were observed on the yellowness
increase rate in chicken TAO comparing with fish TAO or potato TAO. The estimated
average yellowness increase rates for potato/chicken/fish were 0.021/2.847/4.184 per minute.
Overall, thermal abuse of the oil significantly increased the total color difference (∆E?) of
the frying oil as the accumulative frying time increased (Figure 4.5 and Table 4.2). The total
color difference (∆E?) in fish TAO diverged the fastest, followed by chicken and potato TAOs,
which were statistically significant different from each other. The estimated average total
color difference increase rates for potato/chicken/fish were 0.049/6.202/8.495 per minute.
End-point TAO products investigation. (a) L?. Thermal abuse of oil significantly
reduced the lightness of the color comparing the L? value of the fresh oil with the end TAO
products (Figure 4.6). Multiple comparison tests adjusted for fdr was further conducted.
L? value of the fresh oil (38.86) was significantly higher than that of the potato (24.68 ±
1.63)/chicken (19.56 ± 0.56)/fish (21.00 ± 2.40) TAOs. No significant difference in the L?
value was observed among potato/chicken/fish TAOs end product. (b) a?. Thermal abuse of
oil significantly increased the redness of the color comparing the a? value of the fresh oil with
the end TAO products (Figure 4.6). Multiple comparison tests adjusted for fdr was further
conducted. a? value of the fresh oil (−2.84) was significantly lower than that of the potato
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Figure 4.4: L?a?b? values reflect the color changes of the oil being thermally abused
over time. Multiple linear regression was conducted to evaluate the effects of time and fried foods
(potato was set as the reference level) on the color changes of TAO. Potato TAO is denoted by the
filled circle legend in red solid lines. Chicken TAO is denoted by the filled triangle legend in dotted
lines. Fish TAO is denoted by the filed square legend in blue dashed lines.
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Table 4.2: Color changes of TAO over time. Color changes of TAO over time were
characterized by lightness (L?), redness (a?), yellowness (b?) and total color difference (∆E?).
All parameters are presented as mean ± standard error for three replicates.
TAO Time L? a? b? ∆E?
Fresh Oil 0 38.86 −2.84 20.43 0.00
Potato 55 32.50± 1.53 −2.11± 0.03 22.72± 0.87 7.07± 1.10
Potato 110 31.80± 1.29 −1.44± 0.38 24.66± 2.69 9.35± 0.45
Potato 220 30.70± 1.16 −0.14± 0.72 29.14± 3.10 12.91± 1.72
Potato 330 29.25± 0.87 2.12± 1.03 34.40± 2.27 17.87± 1.86
Potato 440 26.37± 1.05 4.46± 1.72 33.25± 4.10 20.03± 2.65
Chicken 50 31.76± 1.32 −1.63± 0.02 25.03± 1.30 8.94± 0.19
Chicken 100 30.89± 0.90 0.16± 0.10 33.30± 1.39 15.57± 0.83
Chicken 200 28.06± 0.68 3.60± 0.39 36.33± 3.69 20.68± 2.42
Chicken 300 25.31± 1.16 7.47± 0.63 33.87± 3.29 22.08± 2.02
Fish 25 31.21± 0.75 −1.09± 0.47 27.18± 3.41 11.36± 1.24
Fish 50 31.99± 0.54 −0.76± 0.82 31.23± 1.69 13.07± 1.57
Fish 100 30.69± 0.35 0.49± 1.14 34.44± 0.84 16.61± 1.11
Fish 150 28.18± 0.94 1.95± 1.69 33.59± 1.48 17.73± 1.96
Fish 200 26.59± 1.29 4.03± 1.90 35.92± 0.46 21.10± 1.33
Fish 250 23.45± 2.29 6.19± 1.93 33.72± 2.98 23.02± 0.87
(7.92± 2.55)/chicken (11.62± 0.41)/fish (7.30± 1.23) TAOs. No significant difference in the
a? value was observed among potato/chicken/fish TAOs end product. (c) b?. No significant
difference was observed comparing the b? value of the fresh oil with the end TAO products
(Figure 4.6). The b? value of the fresh oil (20.43) and the potato (36.77 ± 1.39)/chicken
(30.60± 0.02)/fish (31.06± 4.14) TAOs end product fell into the same range. (d) ∆E?. In
summary, thermal abuse of the oil significantly changed its color comparing the ∆E? value
of the fresh oil with the end TAO products (Figure 4.6). Multiple comparison tests adjusted
for fdr was further conducted. ∆E? value of the fresh oil (0) was significantly lower than that
of the potato (24.36± 1.15)/chicken (26.17± 0.65)/fish (24.13± 0.79) TAOs. No significant
difference in the ∆E? value was observed among potato/chicken/fish TAOs end product.
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Figure 4.5: ∆E? values reflect the total color difference of the TAOs comparing with
the fresh oil over time. Multiple linear regression was conducted to evaluate the effects of time
and fried foods (potato was set as the reference level) on the total color difference of TAO. Potato
TAO is denoted by the filled circle legend in red solid lines. Chicken TAO is denoted by the filled
triangle legend in dotted lines. Fish TAO is denoted by the filed square legend in blue dashed lines.
4.3.2 Viscosity changes of TAO over time
Thermal abuse of the oil significantly increased its viscosity as the accumulative frying time
increased (Figure 4.7 and Table 4.3). The viscosity increase rate of the oil was the fastest in
fish TAO, followed by chicken and potato TAOs, which were statistically significant different
from each other. The estimated average viscosity increase rates for potato/chicken/fish were
0.013/2.218/3.563 mPa.S per minute.
End-point TAO products investigation. Thermal abuse of the frying oil significantly
increased its viscosity comparing the the value obtained for the fresh oil with the end TAO
products (Figure 4.8). Viscosity of the frying oil followed the order of Fish TAO (56.881±
0.229 mPa.S) > Chicken TAO (56.295±0.093 mPa.S) > Potato TAO (53.248±0.147 mPa.S)
> fresh TAO (48.521 mPa.S), which are significantly different from each other according to
the fdr multiple comparison test.
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Figure 4.6: Thermal abuse of the frying oil significantly changed its color (∆E?):
end TAO products possessed decreased lightness (L? value) and increased redness (a?
value) comparing with the fresh oil. Fresh oil is represented by gray bar. Potato/Chicken/Fish
TAO end products are denoted by red/green/blue bars respectively. Groups with different letters
assigned indicate they were significantly different from each other.
Table 4.3: Thermal abuse of the frying oil significantly increased its viscosity over
time. Viscosity is presented as mean ± standard error for three replicates.
TAO Time Viscosity (Pa.S)
Fresh Oil 0 0.0480
Potato 110 0.0494± 0.0006
Potato 330 0.0517± 0.0006
Potato 550 0.0532± 0.0005
Chicken 100 0.0505± 0.0002
Chicken 300 0.0531± 0.0001
Chicken 450 0.0563± 0.0004
Fish 50 0.0501± 0.0008
Fish 150 0.0521± 0.0003
Fish 250 0.0547± 0.0011
Fish 325 0.0569± 0.0012
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Figure 4.7: Thermal abuse of the frying oil significantly increased its viscosity over
time. Potato TAO is denoted by the filled circle legend in red solid lines. Chicken TAO is denoted
by the filled triangle legend in dotted lines. Fish TAO is denoted by the filed square legend in blue
dashed lines.
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Figure 4.8: Viscosity of the end fish TAO was significantly higher than the end chicken
TAO, followed by the end potato TAO and the fresh oil. Fresh oil is represented by gray
bar. Potato/Chicken/Fish TAO end products are denoted by red/green/blue bars respectively.
Groups with different letters assigned indicate they were significantly different from each other.
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4.3.3 Peroxide value (POV) changes of TAO over time
Peroxide value (POV) reflects the primary oxidation degree of oil. Thermal abuse of the
oil accelerated the oxidation, leading to a drastic increase of POV as the accumulative
frying time being extended (Figure 4.9 and Table 4.4). The rate of increase of POV started
to decline at approximately 100 min of additive frying time, indicating that the primary
oxidation products began to break down under prolonged thermal abuse of the oil. POV
accumulation rates of fish and chicken TAOs were significantly higher than the potato TAO.
Note that potato TAO did not prompt significant increase of POV under the time frame
being investigated. There is a trend that the POV increase rate of fish TAO was higher than
the chicken TAO (p = 0.072), which did not satisfy the statistical significance threshold of
0.05. No estimated POV increase rate was reported due to the fact that the patterns of
POV change were not linear (Figure 4.9).
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Figure 4.9: Thermal abuse of the frying oil increased its peroxide value (POV) over
time. Potato TAO is denoted by the filled circle legend in red solid lines. Chicken TAO is denoted
by the filled triangle legend in dotted lines. Fish TAO is denoted by the filed square legend in blue
dashed lines.
End-point TAO products investigation. Thermal abuse of oil significantly increased
the POV of the fish TAO when comparing the POV obtained for fresh oil with that of the
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Table 4.4: Thermal abuse of the frying oil increased its peroxide value (POV) over
time. Peroxide value (POV) is presented as mean ± standard error for three replicates.
TAO Time Peroxide Value (meq/kg)
Fresh Oil 0 0.30
Potato 110 1.83± 0.54
Potato 220 1.58± 0.36
Potato 330 2.29± 0.70
Potato 440 1.53± 0.31
Chicken 100 12.20± 6.20
Chicken 200 12.67± 5.48
Chicken 300 13.69± 4.79
Fish 25 4.31± 0.74
Fish 50 11.45± 3.71
Fish 100 18.09± 2.00
Fish 150 12.71± 1.33
Fish 200 14.77± 2.40
Fish 250 18.10± 6.63
end fish TAO (Figure 4.10). The endpoint POV of Fish TAO (17.62 ± 3.19 meq/kg) was
significantly higher than potato TAO (1.42± 0.54 meq/kg) and fresh oil (0.30 meq/kg). No
significant differences were observed between the chicken TAO POV (7.83 ± 4.33) and the
potato/fish TAOs, as well as with the fresh oil.
4.3.4 P-anisidine value (pAV) changes of TAO over time
P-ansidine value (pAV) reflects the secondary oxidation degree, which corresponds to the rel-
ative amounts of non-volatile carbonyl compounds degraded from fatty acid hydroperoxides.
Thermal abuse of the oil significantly increased its pAV as the additive frying time being
extended (Figure 4.11 and Table 4.5). The pAV increase rate of the oil was the fastest in
fish TAO, followed by chicken and potato TAOs, which were statistically significant different
from each other. The estimated average pAV increase rates for potato/chicken/fish were
0.16/19.05/29.50 per minute.
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Figure 4.10: Peroxide value (POV) was significantly elevated in the end TAO as
compared to the fresh oil. Fresh oil is represented by gray bar. Potato/Chicken/Fish TAO end
products are denoted by red/green/blue bars respectively. Groups with different letters assigned
indicate they were significantly different from each other.
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Figure 4.11: Thermal abuse of the frying oil significantly increased its p-anisidine
value (pAV) over time. Potato TAO is denoted by the filled circle legend in red solid lines.
Chicken TAO is denoted by the filled triangle legend in dotted lines. Fish TAO is denoted by the
filed square legend in blue dashed lines.
End-point TAO products investigation. Thermal abuse of oil significantly acceler-
ated the secondary oxidation comparing the pAV of the fresh oil with the end TAO products
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Table 4.5: Thermal abuse of the frying oil significantly increased its p-anisidine value
(pAV) over time. p-anisidine value (pAV) is presented as mean ± standard error for three
replicates.
TAO Time P-anisidine Value
Fresh Oil 0 0.15
Potato 55 11.55± 0.39
Potato 110 16.77± 0.38
Potato 220 29.72± 0.97
Potato 330 43.60± 2.56
Potato 440 58.19± 4.65
Potato 550 72.54± 7.98
Chicken 50 17.94± 0.44
Chicken 100 26.84± 1.02
Chicken 200 47.86± 1.61
Chicken 300 68.21± 2.65
Chicken 400 73.24± 0.63
Chicken 450 76.67± 1.36
Fish 25 17.04± 1.70
Fish 50 22.74± 0.72
Fish 100 40.34± 2.45
Fish 150 51.20± 4.19
Fish 200 58.67± 1.94
Fish 250 69.99± 2.92
Fish 300 78.64± 4.97
Fish 325 75.86± 0.42
(Figure 4.12). pAV of the fresh oil (0.15) was significantly lower than that of the potato
(72.54± 7.98)/chicken (77.67± 1.27)/fish (79.91± 4.06) TAOs. No significant difference in
the pAV was observed among potato/chicken/fish TAOs end product.
4.3.5 Free fatty acid (FFA) changes of TAO over time
Free fatty acid (FFA) are produced from hydrolysis of triglycerides in frying oil. Thermal
abuse of the oil significantly increased FFA of the frying oil as the accumulated frying time
extended (Figure 4.13 and Table 4.6). FFA content of Fish TAO increased at a rapid rate
followed by chicken and potato TAOs, which were statistically significant different from
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Figure 4.12: Thermal abuse of the frying oil significantly accelerated the secondary
oxidation reactions in end TAO products versus the fresh oil. Fresh oil is represented by
gray bar. Potato/Chicken/Fish TAO end products are denoted by red/green/blue bars respectively.
Groups with different letters assigned indicate they were significantly different from each other.
each other. The estimated average FFA content increase rates for potato/chicken/fish were
0.0005/0.0927/0.1372 % of oleic acid per minute, which is the frying time.
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Figure 4.13: Free fatty acid (FFA) content of TAOs accelerated significantly over time.
Potato TAO is denoted by the filled circle legend in red solid lines. Chicken TAO is denoted by
the filled triangle legend in dotted lines. Fish TAO is denoted by the filed square legend in blue
dashed lines.
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Table 4.6: Free fatty acid (FFA) content of TAOs accelerated significantly over time.
Free fatty acid content is presented as mean ± standard error for three replicates.
TAO Time Free Fatty Acids (% of Oleic Acid)
Fresh Oil 0 0.0735
Potato 110 0.1227± 0.0079
Potato 220 0.1466± 0.0200
Potato 330 0.1724± 0.0211
Potato 440 0.1894± 0.0067
Potato 550 0.2125± 0.0118
Chicken 100 0.1610± 0.0277
Chicken 200 0.1921± 0.0176
Chicken 300 0.2487± 0.0079
Fish 25 0.1339± 0.0225
Fish 100 0.1892± 0.0327
Fish 150 0.2189± 0.0285
Fish 200 0.2617± 0.0306
Fish 250 0.3239± 0.0389
End-point TAO products investigation. Thermal abuse of oil significantly accel-
erated the hydrolysis reaction comparing the FFA content of the fresh oil with the end
TAO products (Figure 4.14). FFA cotent of fish (0.392 ± 0.033 % oleic acid) and chicken
(0.364±0.016 % oleic acid) TAO were significantly higher than the potato TAO (0.212±0.012
% oleic acid), followed by the fresh oil (0.073 % oleic acid). No significant difference in the
FFA content was observed between fish and chicken TAOs.
4.3.6 Polar compounds percentage changes of TAOs
The polar compounds percentage for fresh oil was approximately 3.84%. For the end
potato/chicken/fish TAOs, it reached 7.724%/15.01%/15.21% respectively. Only one repli-
cation’s result for every TAO was reported, due to the technical difficulties encountered
during the measurement and time limitation.
73
cb
a a
0.0
0.1
0.2
0.3
0.4
0.5
Fresh Oil Potato Chicken Fish
Frying Oil
Fr
ee
 F
a
tty
 A
cid
s 
(%
 of
 O
lei
c A
cid
)
TAO
Fresh Oil
Potato
Chicken
Fish
Figure 4.14: Thermal abuse of the frying oil significantly accelerated the hydrolysis
in end TAO products versus the fresh oil. Fresh oil is represented by gray bar.
Potato/Chicken/Fish TAO end products are denoted by red/green/blue bars respectively. Groups
with different letters assigned indicate they were significantly different from each other.
4.3.7 Fatty acids composition changes of TAOs
The analytical conditions used in our experiments were able to detect 36 out of 37 fatty acid
components in the reference Supelco 37-component FAME mix (Figure 4.15). The resolution
of peak 31 (C20:4) and 32 (C23:0) was not clear. Since methyl lignocerate (C23:0) rarely
occurs in soybean oil or the foods being fried in our study naturally, the lack of resolution
of peak 31 and 32 would not affect our final results.
Major fatty acid component composition changes. Palmitic acid (C16:0), stearic
acid (C18:0), oleic acid (C18:1), linoleic acid (C18:2) and α-linolenic acid (C18:3n3) were the
major fatty acid components in TAOs. Their component composition changes are presented
in Figure 4.16. (a) Palmitic acid (C16:0). There was a trend that the percentage of
palmitic acid (C16:0) in the end fish TAO (13.47± 1.08%) was higher than the end potato
TAO (10.91± 0.15%) and fresh oil (10.27%) according to the multiple comparison test. No
significant difference was detected between the proportion of palmitate (C16:0) in end fish
TAO and end chicken TAO (11.85± 0.23%). (b) Stearic acid (C18:0). The stearic acid
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Figure 4.15: Supelco 37-component FAME mix in dichloromethane chromatograph.
The number of each peak is denoted in the chromatograph. Please refer to their corresponding
components in Table 4.1.
(C18:0) percentages for the end fish/chicken/potato TAOs were 4.53±0.09/4.26±0.07/4.31±
0.09%, which were shown to be significantly higher than the fresh oil (3.82%) according to
the multiple comparison test. (c) Oleic acid (C18:1). End fish TAO (28.32± 0.88%) had
a significantly higher percentage of oleic acid (C18:1) than the end chicken (23.61± 0.28%)
and potato (23.56 ± 0.07%) TAOs, as well as than the fresh oil (23.64%) according to the
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multiple comparison test. (d) Linoleic acid (C18:2). End fish TAO (47.56± 1.59%) had
a significantly lower percentage of linoleic acid (C18:2) than the end chicken (53.40±0.25%)
and potato (53.86 ± 0.10%) TAOs, as well as than the fresh oil (54.63%) according to the
multiple comparison test. (e) α-linolenic acid (C18:3n3). End fish TAO (6.11± 0.35%)
had a significantly lower percentage of α-linolenic acid (C18:3n3) than the end chicken (6.89±
0.07%) and potato (7.37± 0.09%) TAOs, as well as than the fresh oil (7.64%) according to
the multiple comparison test.
Other fatty acid component composition changes. Representative fatty acid
component profiles are presented in Figure 4.17. Myristic acid (C14:0), palmitic acid (C16:0),
palmitoleic acid (C16:1), stearic acid (C18:0), oleic acid (C18:1), linoleic acid (C18:2),
α-linolenic acid (C18:3n3), γ-linolenic acid (18:3n6), arachidic acid (C20:0), eicosenoic
acid(C20:1), eicosadienoic acid (C20:2) and docosanoic acid (C22 : 0) were commonly
noted fatty acids in fresh oil and end potato/chicken/fish TAOs. Their compositions
are demonstrated in Table 4.7. Fish TAO possessed a significantly higher proportion of
eicosadienoic acid (C20:2) than the fresh oil and potato/chicken TAOs. Trace amount of
trans-linolelaidic acid (C18 : 2) was detected in one of the end fish TAO sample.
4.3.8 Spearman’s correlation analysis of TAO characteristics and
lung TNC in mice fed with TAO diet
Spearman’s correlation was conducted between the TAO characteristics and lung TNC in
mice fed with TAO diet. Spearman’s rho and p-value are presented in Table 4.8. Viscosity,
peroxide value, p-anisidine value, free fatty acid content, polar compounds percentage,
palmitic acid (C16:0) percentage, and eicosadienoic acid (C20:1) percentage of end TAOs
were positively correlated (p < 0.10) with the metastatic lung TNC in mice fed with end
TAO diet. Linoleic acid (C18:2) percentage and α-linolenic acid (C18:3n3) percentage were
negatively correlated (p < 0.10) with the metastatic lung TNC.
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Figure 4.17: Fatty acid components chromatograph of end TAO products and fresh
oil. Chromatographs for end potato/chicken/fish TAO were obtained from trial 2/2/3 respectively.
Only peak number is denoted in the chromatograph, please refer to the corresponding fatty acid
component in Table 4.1. If the peak is denoted with number zero, then the relative component did
not match for any of the 37 fatty acid standard being investigated.
4.4 Discussion
In the United States, regulations have not been established by the Food and drug Admin-
istration (FDA) to control for quality of frying oil in terms of its physical and chemical
characteristics. It is due to the lack of evidence determining the link between the character-
istics of frying oils used in deep frying and their corresponding deleterious impacts on human
health [81]. In this study, we characterized the physical (color and viscosity) and chemical
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Table 4.7: Percent fatty acid composition of the commonly occurring fatty acids in
frying oil. Potato/Chicken/Fish TAOs refer to the end TAO products. Groups with different
letters assigned indicate they were significantly different from each other within each fatty acid
(across each row). Letters were assigned with star symbol if the p-value of the one-way ANOVA
was not less than 0.05.
Fatty Acids Fresh Oil Potato TAO Chicken TAO Fish TAO
14:0 0.13%b∗ 0.20± 0.05%ab∗ 0.16± 0.02%b∗ 0.45± 0.22%a∗
16:0 10.12%b∗ 10.71± 0.15%b∗ 11.64± 0.22%ab∗ 13.12± 1.00%a∗
16:1 0.11%b∗ 0.17± 0.06%b∗ 0.13± 0.01%b∗ 0.50± 0.12%a∗
18:0 3.77%b 4.23± 0.08%a 4.19± 0.06%a 4.41± 0.08%a
18:1 23.30%b 23.14± 0.07%b 23.19± 0.28%b 27.58± 0.75%a
18:2 53.86%a 52.90± 0.08%a 52.45± 0.29%a 46.35± 1.72%b
18:3n3 7.54%a 7.23± 0.09%a 6.76± 0.07%a 5.95± 0.36%b
18:3n6 0.30%a∗ 0.32± 0.02%a∗ 0.39± 0.04%a∗ 0.31± 0.07%a∗
20:0 0.26%a∗ 0.31± 0.02%a∗ 0.32± 0.03%a∗ 0.29± 0.03%a∗
20:1 0.26%a∗ 0.36± 0.03%a∗ 0.41± 0.03%a∗ 0.45± 0.07%a∗
20:2 0.05%b 0.09± 0.01%b 0.07± 0.01%b 0.29± 0.03%a
22:0 0.31%a∗ 0.36± 0.03%a∗ 0.33± 0.06%a∗ 0.29± 0.01%a∗
(peroxide value, p-anisidine value, free fatty acid contents, polar compounds percentage and
fatty acid composition) changes of oil deep-frying three difference kind of foods (potato
strips, chicken strips and fish nuggets). The goal of our study is to investigate the physical
and chemical characteristics of TAO, which may be linked to the stimulation of breast cancer
metastasis in vivo.
It is well-documented that the color of frying oil darkens, smoking point decreases and
polymerization leads to an increase of viscosity, the formation of more polar degradation
products corresponds to elevated dielectricity, upon repeated usage of frying oils [175]. The
physical changes of TAOs and their relevance to breast cancer metastasis in vivo will be
analyzed in detail in the following.
The most noticeable change in the oil during frying was darkening, as shown in
Figure 4.3. The color development in frying oil could be mainly attributed to non-enzymatic,
Maillard browning reactions and polymerization [176]. Maillard reaction is the reaction
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Table 4.8: Correlation between end TAO characteristics and metastatic lung TNC in
mice fed with four low-fat diets. Parameters are denoted in red if the correlation was positive
with a p-value less than 0.10. Parameters are denoted in green if the correlation was negative with
a p-value less than 0.10.
Correlation With Metastatic Lung TNC Spearman’s rho P -value
L? −0.80 0.33
a? 0.40 0.75
b? 0.40 0.75
∆E? 0.40 0.75
Viscosity 1.00 0.08
Peroxide value 1.00 0.08
P-anisidine value 1.00 0.08
Free fatty acid content 1.00 0.08
Polar compounds percentage 1.00 0.08
14 : 0 percentage 0.80 0.33
16 : 0 percentage 1.00 0.08
16 : 1 percentage 0.67 0.33
18 : 0 percentage 0.67 0.33
18 : 1 percentage 0.33 0.75
18 : 2 percentage −1.00 0.08
18 : 3n3 percentage −1.00 0.08
18 : 3n6 percentage 0.33 0.75
20 : 0 percentage 0.33 0.75
20 : 1 percentage 1.00 0.08
20 : 2 percentage 0.67 0.33
22 : 0 percentage 0.33 0.75
between amino acids and reducing sugars that gives food brown color. Non-enzymatic
browning reactions take place between the lipid oxidation products and amines, amino
acids or proteins. Particularly, Lysine, histidine, and methionine originating from fried
food react with oxidative compounds from lipids (aldehydes, epoxides, hydroxyketones, and
80
dicarbonylic compounds), which were correlated with the intensity of browning [11] [177].
Color change during the course of frying was suggested as a measurement for oil quality [178]
[179]. Xu [180] reported that there was a strong correlation (r = 0.96, p < 0.001) between
the polar compound contents and color of frying oil. Note that the rate of color changes
could be altered by many factors. The changes depend on the kind of frying oil, type/size of
food being fried, initial quality of oil and frying parameters (such as temperature, time, type
of fryer, oil/food ratio, replenishment of oil). In our study, the main focus was to investigate
the impact of frying time and foods on the color changes of frying oil, and link the color
changes to its physiological impact in vivo. Food being fried greatly influenced the rate of
color formation in the frying oil. Clearly, both fish nuggets and chicken strips accelerated the
darkening of the frying oil faster than the potato strips (Figure 4.4), which could be partially
due to the breading. Lazarich et al. showed that fried food with breading forms color in the
frying oil much more rapidly [181]. Fried food exchanged components with the oil during
frying, for instance, carbohydrates, proteins, fats, phosphates, sulfur compounds and trace
minerals [182]. Those compounds contributed to the color formation by reacting with the
oil or its derivatives of breakdown. The differences in the oil color changing rates between
fish/chicken TAOs and potato TAO could also be attributed to their different food matrix
composition. Both breaded fish nuggets and chicken strips were abundant in carbohydrates
(sugar, wheat flour starch from the breading), protein and phosphorus. Potato was mainly
composed of starch, fiber and other trace amounts of minerals. More importantly, the color
changes of fish TAO was associated with its breast cancer metastasis promotion ability in
vivo (Figure 4.1). It indicates that color could be used as one of the physical indicators for
TAO’s physiological deleterious impacts in vivo.
The common range for the viscosity of liquid oils is typically between 30 and 60 mPa.S
at room temperature, and majority of them fall into the category of Newtonian liquids [183]
[184], which is consistent with our study. It is well-recognized that increase in viscosity
in TAO is due to high molecular weight compounds formation by polymerization reaction
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occurring in the frying oil [81]. Viscosity was shown to be highly correlated (r > 0.97) with
the polar compounds in the frying oil [185] [186]. It was also noted that food tended to absorb
more frying oil when it is fried in oil with a high viscosity [81]. In our study, we observed
that the viscosity of frying oil increased as the time of frying increased. Increasing rate were
also determined by the type of food being fried: fish TAO > chicken TAO > Potato TAO.
It indicates that more polar compounds were generated in the fish TAO than the chicken
TAO, followed by the potato TAO controlling for the frying time, which is consistent with our
results on polar compounds percentage measurement in 4.3.6. This finding was confirmed in
a previous study that the viscosity of oil frying chicken nuggets was significantly higher than
potato strips [187]. However, there is no literature data comparing the viscosity of oil frying
fish, chicken and potato separately controlling for all the other frying parameters. It appears
that the higher viscosity of the fish TAO, the more aggressive breast cancer metastasis in
vivo when supplemented with low-fat diet, not with high-fat diet (Figure 4.1 and Table 4.8).
These observations, therefore, suggest that the viscosity is another strong physical indicator
for oil deterioration under thermal abuse, which is also biologically relevant to the breast
cancer metastasis exacerbation phenomenon.
As mentioned earlier, oxidation, polymerization, and hydrolysis are the three main
chemical reactions taking place in the oil being thermally abused. Thermal oxidation occurs
between the oxygen and deep-frying oil to form hydroperoxides, free radicals, aldehydes,
conjugated dienoic acids, epoxides, hydroxides and ketones [81] [188]. The mechanism
is very similar to the autoxidation mechanism involving the initiation, propagation, and
termination, with a faster rate [82]. The rate of oxidation depends on multi-faced factors. For
instance, temperature, frying time, turnover rate, filtering of oil, continuous or intermittent
heating or frying, surface area, presence of prooxidant metals (such as iron and copper),
presence of high-temperature antioxidants, presence of silicone anti-foams, types of fried
food and quality/composition of frying oil [81] [188]. Dimeric and cyclic compounds are
the primary products when unsaturated fatty acids undergo oxidation. Carboxylic acids,
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2-alkanones, n-alkanals, lactones, and l-alkanes are the major oxidation products for the
saturated fatty acids [81]. Primary lipid oxidation products are defined as the compounds
which are produced during the initiation and propagation steps of lipid oxidation [189].
Peroxide value measures the amount of fatty acid hydroperoxides produced during primary
oxidation. Hydroperoxide formation rate exceeds their decomposition rate during the initial
stage of oxidation, which is opposite in the later stage of oxidation [127]. Peroxide value is
an appropriate indicator for the changes during initial oxidative reaction [190]. According
to Figure 4.9, peroxide value of fish and chicken TAO increased dramatically from 0.30
to approximately 12 meq/kg after the oil being thermally abused for 100 minutes, during
which the production rate of fatty acid hydroperoxides was significantly faster than the
breakdown rate. Peroxide value stayed around the same level afterwards for fish/chicken
TAO, indicating that the breakdown rate of hydroperoxides caught up with the production
under high temperature of frying. Peroxide value of potato TAO increased slightly from 0.30
to approximately 7.83 meq/kg over the time frame being investigated. It is possible that
the generation of hydroperoxides were slower for potato TAO than fish/chicken TAOs. It is
also possible that the generation and breakdown rate of hydroperoxides for potato TAO fell
in the same range. Therefore, the decrease in peroxide value does not necessarily mean that
the quality of oil is good. The oxidation of oil can not be simply reflected by peroxide value
[191].
Hydroperoxides are unstable and susceptible to decomposition [127]. Secondary lipid
oxidation products are compounds that arise from the decomposition of fatty acid hy-
droperoxides by a number of different reactions (such as β-scission reaction), result in
literally hundreds of different fatty acid decomposition products (for example, aldehydes,
ketones, alcohols, hyrocarbons, volatile organic acids, and epoxy compounds), both volatile
and nonvolatile [189]. Volatile compounds contribute to the off-flavors and off-aromas in
rancid oils, which may be more relevant to the sensory analysis [192]. We focused on the
quantification of the secondary lipid oxidation products and their biological relevance in
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breast cancer metastasis. P-anisidine value measures aldehydes (principally 2-alkenals and
2,4-alkadienals) which conjugate with anisidine to form yellowish products that absorb at
350 nm [127]. An extensive amount of evidence has indicated that p-anisidine value is a
reliable indicator of oxidative deterioration in oils [193]. In our study, we observed that
the p-ansidine value of TAOs increased when being thermally abused in the following rate
order: fish TAO > chicken TAO > potato TAO (Figure 4.11). However, there were no
significant differences of p-anisidine value comparing fish/chicken/potato TAO end products
(Figure 4.12). This is mainly due to the fact that accumulative frying time corresponding
to the end TAO products were not consistent. It does not necessarily mean that the end
fish/chicken/potato products reached equivalent secondary oxidative deterioration degree.
Because p-anisidine value reflects the amount of one specific category of secondary oxidative
products, other measurement of the secondary oxidation products could be adopted in the
future study such as thiobarbituric acid test, totox value and oil stability index measurement,
and hydrocarbons and fluorescence assay [127]. Cumulatively, our data suggest that the
secondary oxidation rate of fish TAO was significantly higher than the chicken/potato TAOs.
This may in part explain the aggressive breast cancer metastasis in mice feeding low-fat diet
containing end fish TAO product (Figure 4.1), although further validation will be needed to
better quantify the oxidative deterioration of TAO other than peroxide value and p-anisidine
value.
Triglyceride hydrolysis is accelerated in frying oil resulting from the high processing
temperature and introduction of water from the food [189]. Free fatty acids, mono- and
diacylglycerols, and glycerol are produced during hydrolytic reactions [175]. In addition
to hydrolysis, free fatty acids are also formed by oxidation. Consequently, the free fatty
acid content of the frying oil increases with the cycle of frying [194], which was confirmed
in our study. Free fatty acids provide off-flavor, reduce oxidative stability, cause foaming,
and reduce smoke point [189]. Short and unsaturated fatty acids are more susceptible for
hydrolysis in oil than the long and saturated fatty acids [195]. The thermal hydrolysis of
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oil could also be accelerated by the presence of di- and mono-acylglycerols, glycerol and
free fatty acids [196]. The measured free fatty acid content of the fresh soybean oil used
in our study was 0.073%; and as it was lower than 0.1%, it was indicative of freshness
[197]. Oils with free fatty acid content above 2% are considered unusable, as reported in the
general guidelines for frying meat and poultry products by the United States Department
of Agriculture (USDA) Food Safety and Inspection Service’s Meat and Poultry Inspection
Manual in 1987 [198]. Nevertheless, the relationship between free fatty acids and quality of
used frying remained contradicting. Many researchers have concluded that free fatty acid
measurement is not considered as a reliable marker of deterioration of oils during frying
[199] [200]. According to Figure 4.13, the hydrolysis rate of the frying oil followed the order:
fish TAO > chicken TAO > potato TAO. Hence, types of fried food played an important
role in raising the hydrolysis rate of frying oil fixing accumulative frying time. At the end
frying points, fish/chicken TAO had higher free fatty acid contents than the potato TAO
(Figure 4.14). We also observed significant differences in the free fatty acid contents between
all end TAO products and the fresh oil (Figure 4.14). Although the free fatty acid content
for the chicken TAO turned out to be significantly higher than the fresh oil, we only found
a trend in the mouse model that the tumor nodule counts of the mice fed with chicken TAO
was higher than the fresh oil supplemented with low-fat diet (Figure 4.1). Collectively, the
free fatty acid content can partially reflect the biological consequence of consuming end TAO
products, leading to breast cancer metastasis in vivo, which was the most pronounced in the
fish TAO supplemented with low-fat diet.
In some European countries, maximum polar compounds percentage is regulated to
control for the quality of frying oil and deciding the point of TAO to be discarded [81].
The maximum threshold varies around 25%. One of the recommended and widely accepted
limit is 24% [175]. As mentioned earlier, the polar compounds percentage is positively
correlated with the viscosity of the frying oil [185] [186]. Similarly, polymers cause the
higher oil absorption into fried food. Polymers also accelerate oil degradation, reduce the
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heat transfer, produce foam, and develop undesirable color in food [82]. Linoleic acid (C18:2)
is more easily polymerized than oleic acid (C18:1) under thermal abuse [201] [202]. We
observed that the polar compounds percentage of TAOs started from 3.84% in fresh oil, and
increased approximately two to three-fold to 7.72% to 15.21% in the end products (Please
refer to 4.3.6). TAOs could be defined as moderately thermally abused oils in this sense
considering the common upper limit of polar compounds percentage for frying oil is around
24%. The end polar compounds percentage for chicken and fish TAOs exceeded potato
TAO by more than a hundred percent, showing their elevated deterioration degrees. With
reference to their ability promoting breast cancer metastasis in vivo (Figure 4.1), the polar
compounds percentage links the oil polymerization to its biological impact to some extent
(Table 4.8). However, more replicates of end TAO products’ polar compounds percentage
need to be measured in the future to confirm this point. More importantly, other alternative
methods using micro columns [203], or High Performance Liquid Chromatography (HPLC)
methods [204] [205] could also be considered to save time and effort, versus the recommended
standard silica gel column chromatography method [173].
Fatty acid composition changed during deep-frying and this change depended on the
fried food. Polyunsaturated fatty acids decrease, and the total saturated fatty acids increase
in frying oil [81]. The most significant decrease is expected in oils with the most highly
unsaturated fatty acids [81]. Previous research [11] [197] [206] also illustrated that there is
a dynamic mass exchange between the frying oil and fried food. It was demonstrated by
the presence of food components (i.e., cholesterol, phospholipid, lipid-soluble vitamins) in
the frying oil [11]. The lipid content of fried foods like fish or chicken was shown to be
lower than before frying, confirming the lipid interchange between fried food and frying oil
[207]. In our study (Figure 4.17), we observed that the saturated fatty acids (both palmitic
acid <C16:0> and stearic acid <C18:0>) proportion increased in TAOs comparing with the
fresh oil, confirming the results reported in the literature as mentioned earlier [81]. It was
unexpected to find that Fish TAO had a higher amount of oleic acid (C18:1) than the fresh
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oil (Figure 4.17). However, oleic acid (C18:1) is one of the most abundant fatty acids found
in raw catfish, together with palmitic acid (C16:0) and linoleic acid (C18:2) [208]. It is very
likely that the increase of oleic acid (C18:1) in fish TAO originated from the raw catfish.
Similarly, the increased amount of eicosadienoic acid (C20:2) in fish TAO (Table 4.7) could
also derive from the raw catfish fillet. Fresh oil had a significantly higher percentage of both
linoleic acid (C18:2) and α-linolenic acid (C18:3n3) than fish oil (Figure 4.17). It indicates
that the degree of fish TAO deterioration surpassed chicken/potato TAOs in terms of the
breakdown of PUFAs.
Considerably large amounts of oxidized fatty acids (Epoxy-, keto- and hydroxy- fatty
acids) are produced in thermally deteriorated oils [209] [210], most of them are unexpectedly
stable, being the decomposition products of hydroperoxides [211] and are reported to be
toxic [212]. Frying oil with 34% polar compounds contains approximately 1900 mg/kg cis
monoepoxy oleic acid (C18:1E), and 1900 mg/kg cis diepoxy linoleic acid (C18:2E) [213].
Polyunsaturated fatty acids (PUFAs) are the major precursors for the generation of oxidized
fatty acids, which partially explains the decrease in the amount of PUFAs in the process of
deep-frying [214]. In human studies, the absorption of oxidized fatty acids has been shown
to be higher than the unchanged fatty acids, taking into account that they have greater
polarity and comparable molecular weight [215] [216]. An important agenda for future
research will involve quantifying the oxidized fatty acids in TAOs, especially the epoxy-fatty
acids. Nevertheless, based on the results obtained from the animal study (Figure 4.1), we
can conclude that there is a strong link between the breakdown of PUFAs in fish TAO and
the exacerbation of breast cancer in mice fed with Fish TAO in the low-fat group. Future
research needs to validate that this physiological response is resulting from the oxidized fatty
acids being produced in TAOs.
Taking everything into account, although there is a wealth knowledge about the TAO
characterization in terms of quality control and improvement, much less is known about their
direct biological impact on breast cancer in vivo, and how it is linked the corresponding TAO
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characteristics. This study is the first to unveil the link through collaboration between food
scientists and nutritionists. We provided pivotal evidence that the biological consequence in
breast cancer metastasis by incorporating TAO as part of the diet, which could be associated
with its distinct physical and chemical characteristics, for example, viscosity, p-anisidine
value, free fatty acid content, polar compounds and fatty acid composition. Repeated
exposure to high temperature, during deep frying, led to significant deterioration of oils
and accumulation of high concentration of undesirable compounds. These have been linked
with negative health impacts. The deterioration of oils and accumulation of undesirable
compounds during frying depended on the food in the order of fish TAO > chicken TAO >
potato TAO. Last and the most important, the deterioration of and undesirable component
formation in TAO positively correlated with breast cancer metastasis in the preclinical model.
Understanding the relationship between quality of oils and the accumulation of undesirable
compounds could help change strategy for patients suffering from breast cancer or other
oxidative stress associated diseases such as cardiovascular disease. The results reported in
this study is the initial step to protect consumers by looking closely at undesirable compounds
from foods with negative effects on health.
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Chapter 5
Conclusions and Future Directions
In this dissertation, the modulation effects of food processing on breast cancer were studied
in two separate studies.
In the first study, the effect of soy processing on breast cancer was investigated (Chapter
3). Soy processing levels modulate breast cancer tumor growth. Minimally processed
soy flour diet prevents isoflavones from stimulating breast cancer tumor growth; whilst
highly processed purified isoflavone mix diet exacerbates breast cancer tumor growth [8]
[56]. This study [130] is the first to use bioinformatics approaches to investigative whole-
genome expression pattern changes modulated by soy processing toward breast cancer. This
study highlights: 1) genes promoting or inhibiting tumor growth; 2) regulation of cancer
cell signaling pathways; 3) differences in estrogen-responsive gene expression; 4) regulation
of immune responses and 5) correlation of the DEGs expression level to survival time among
ER+ breast cancer patients treated with Tamoxifen. In detail, soy flour diet up-regulated
tumor suppressor genes (such as BLNK ) and down-regulated oncogenes (for example, MYB);
Purified isoflavone mix diet was shown to stimulate the opposite regulation cascade. Soy
processing affects cancer cell signaling and cellular processes [159]. Minimally processed
soy flour diet down-regulated NPM3 participating chromatin modification pathway, and
down-regulated c-MYC in cell cycle. Highly processed purified isoflavone mix diet down-
regulated JAG1 in NOTCH pathway and up-regulated CAPN2 engaging in apoptosis.
Soy processing alters estrogen-responsive genes expression. Soy flour abrogates increase of
estrogen responsive gene expression; for instance, expression of NRIP1 was down-regulated.
Purified isoflavone mix diet enhances estrogen-responsive gene expression by up-regulating
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expression of MYBL1 and ERG3. Soy processing regulates immune responses. Soy flour
diet strengthens immune responses, whilst purified isoflavone mix diet weakens them. Soy
processing correlates with survival time of breast cancer patients . Soy flour diet might
prolong survival time of breast cancer patients to more than five years. Purified isoflavone
mix diet is linked to shorter survival time of less than five years. To conclude, this
study provides strong evidence that there is a difference in biological responses between
consumption of soy flour versus purified isoflavone mix as part of diet in a preclinical model
for breast cancer. It is advisable for the post-menopausal patients with estrogen receptor
positive breast cancer to take in isoflavones from minimally processed form of food rather
than highly processed supplementation. Future studies will be designed to characterize the
composition of bioactive components other than isoflavones in the soy flour diet, and their
anticipated protective effects on breast cancer growth will be investigated. Further, studies
will be conducted to demonstrate that the genomic changes observed in our study impact
cancer cell proliferation and apoptosis.
In the second study, physical and chemical characteristics of moderately thermally abused
oil (TAO) were studied (Chapter 4). Broader impacts on breast cancer metastasis and other
oxidative stress induced diseases such as cardiovascular disease were discussed. This study
promotes awareness that the connection might exist between thermally abused of frying oil
for repeated time and its adverse impact on human health. Repeated exposure to high
temperature, during deep frying, led to significant deterioration of oil and accumulation of
high concentrations of undesirable compounds. When fixing other parameters in deep-frying,
deterioration of oil was dictated by the food being fried in the order of fish TAO > chicken
TAO > potato TAO. TAOs possessed distinct characteristics of color, viscosity, p-anisidine
value, free fatty acids, polar compounds and fatty acid composition. Most importantly,
deterioration of and undesirable component formation in TAO positively correlated with
breast cancer metastasis in the preclinical model. This study revealed the connection between
consumption of thermal abuse of frying oil for repeated time and its stimulation on breast
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cancer metastasis in vivo. Future studies will be continued to characterize the undesirable
components in TAO, such as epoxy- fatty acids and cyclic fatty acids. Further, in order
to verify the adverse impact of consuming food fried by TAO in vivo, fried food can be
incorporated as the energy nutrients of the diet used in preclinical model.
To conclude, this dissertation demonstrates the modulation effects of food processing
on breast cancer from two different perspectives. The whole-genome expression differences
comparing minimally processed soy flour diet versus highly processed purified isoflavone
mix diet revealed clear differences in the modulation of tumor growth in a preclinical
model of breast cancer. It elucidated the underlying molecular mechanisms that food
processing could abrogate the prevention of breast cancer tumor growth by ousting food
matrix effects in whole food systems. As a popular food processing method in food industry,
at restaurants and households, deep-frying was inspected from its health impact perspective.
This dissertation raised awareness by confirming the proposed link between the physical and
chemical characteristics of moderately thermally abused oil (TAO) and its biological breast
cancer metastasis stimulation response in a preclinical model. It shows that although food
processing has brought convenience and safety to most developed societies, it might come
at a cost that is still difficult to quantify in terms of its impact on nutrition and health.
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